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ABSTRACT 
This thesis describes the isolation, purification and structure elucidation of 
secondary metabolites from three plants which were selected based on phytochemical 
and ethnotherapeutic considerations. The structures were determined using modem 
pulse techniques in high field NMR spectroscopy, mass spectrometry, chemical 
derivatization and synthesis of two new metabolites. 
The first plant studied was Eupatorium adenophorum ( crofton weed), 
recognized as a cause of chronic respiratory diseases in horses, and related to the 
plant E. rugosum in the U.S.A. which is responsible for milk sickness in humans and 
trembles in animals. The bioactivity-directed fractionation of the active components 
was carried out elsewhere and was followed by final purification. The structure 
determination of the flavonoid eupalitin-3-0-galactoside (20) and the toxic cadinene 
9-oxo-10, 11-dehydroageraphorone (21) are described. 
The second plant studied was Wedelia asperrima Benth., which from 
previous toxicity-guided isolation had yielded the toxic compound wedeloside (17) 
and its rhamnosyl derivatives (40) and (41). Chapter III describes a broadly-based 
non-specific isolation and structure elucidation of metabolites from three fractions of 
the plant extract. The triterpenes P-amyrin ( 44) and its acetate ( 45) and keto ( 46) 
derivatives were isolated from the hexane fraction. The dichloromethane fraction 
yielded 2',4',4-trihydroxy-3-methoxychalcone (49) and its 3'-dimethoxy derivative 
(50). The corresponding flavanones (48) and (47) which are isomers of (49) and 
(50), as well as their new 4'-0-P-D-glucopyranosyl derivatives (51), (52) were also 
identified. Chemical synthesis of the new compounds (50) and its flavanone isomer 
( 47) further confirmed the assigned structures. The new wedeloside analog, 4'-0-
sulfated wedeloside (53) and the rhamnosyl wedelosides ( 40) and ( 41) were isolated 
from the n-BuOH fraction. 
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The last chapter describes the chemical study of Wedelia prostata Jacquin, a 
plant used in folk medicine in the Philippines. Although on chemotaxonomic 
grounds it might have been expected to contain wedeloside or its analogs, its 
ethnotherapeutic use suggested the absence of toxic compounds. The hexane fraction 
of the aqueous-methanol extract of the plant yielded poriferasterol (71) and the 
kaurenoic acids (72) and (73), the latter of which have been reported to possess 
pharmacological properties. The most polar fraction of the extract afforded eugenol 
glucoside (74) and its derivatives (75) and (76), a 4-allyl-2,6-dimethoxyphenyl 
glucoside derivative (77) and plucheoside B (78). 
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CHAPTER I 
GENERAL ASPECTS OF 
SECONDARY METABOLISM 
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A. Introduction 
1. Importance of Natural Products Studies 
Most studies on natural products chemistry have been pursued to determine 
the biological activity of secondary metabolites and to exploit their commercial 
viability. Many known secondary metabolites portray important applications in the 
pharmaceutical, agrochemical, and fragrance industries. 
In the pharmaceutical industry, the oldest and most classic example of a 
prescription drug developed from a traditional plant is ephedrine (1). It is isolated 
from the Chinese shrub Ma Huang (Ephedra sinica). Ephedrine is an alkaloid closely 
related to adrenaline and is used pharmacologically to stimulate increased activity of 
the sympathetic nervous system. Another more recent example is artemisinin (2), an 
anti-malarial drug that is isolated from the leaves and flowers of Artemisia annua L. 
(Compositae).1 
HO 
NHCH3 
Ephedrine (1) Artemisinin (2) 
In cancer chemotherapy, there is also a reliance on the use of a number of 
natural products, intact or chemically modified, as well as on purely synthetic 
products some of which are mimics of naturally occurring substances.2 Examples of 
anti-cancer drugs developed include Celiptium® and Taxorete® that are derivatives of 
the naturally occurring compounds ellipticine (3) and taxol (4), respectively. 
There has been growing interest at the National Cancer Institute (NCI) in 
exploring natural products as an untapped source of more promising anti-cancer 
-
d 
3 
agents. Many of the exciting new chemical entities that they have under 
consideration are either natural products or the derivatives of a natural product lead. 3 
NCI has even awarded contracts to collect 20,000 plants from Africa and 
Madagascar, Central and South America, and Southeast Asia for biological 
screening.4 In parallel with this long-standing anti-cancer program, NCI has also 
recently implemented anti-AIDS screening and anti-viral development programs.s 
H 
PhCO-N 0 
I 
Ph 
I 
OH 
N 
H 
Ellipticin (3) 
HO 
PhC0-0 
Taxol (4) 
,0 
In addition to the commercial importance of secondary metabolites , their 
large structural variety has made them important subjects for studies on structure 
elucidation, reaction mechanisms, stereochemistry, as well as synthesis. There have 
been attempts to develop efficient synthetic routes to the secondary metabolites, 
thereby eliminating the dependence on the living organism as the source.6 It was 
thought that the chemical synthesis of bioactive compounds or related analogues 
would be more effective and economical than isolation from natural sources. This is 
true in many cases but in other cases, synthetic analogues are not as effective as their 
natural counterparts. In addition, some synthetic analogues cost many times more 
-
> 
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than natural ones. These reasons, coupled with the fact that some natural products 
with complex structures may be too difficult to synthesize, have led to a resurgence of 
interest in natural sources for bioactive compounds. 1 
2. Terminology 
The term "natural products" has often been used synonymously with 
"secondary metabolites". However, in the 1_992 CIBA symposium 171 on secondary 
metabolites, the term natural products was agreed upon to denote both primary and 
secondary metabolites. A secondary metabolite then, is a natural product but a 
natural product is not necessarily a secondary metabolite. 7 
The term secondary metabolites has been defined in many ways. 8 The first 
seriously scientific use of the "primary/secondary" classification for metabolites in 
modern times according to Bennett8 was apparently found in a sentence in a lecture 
by Albrecht Kassel ( 1891) which translates: "I suggest to call the essential 
components of the cell as primary ones, however, those which cannot be found in 
every growing cell we shall call secondary ones". The same term "secondary" for 
plant products such as alkaloids was revived by Czapek ( 1925) who is reported8 to 
have used the following statement: "the production of such substances (i.e., alkaloids) 
involves processes not inherent to every cell plasma but more of a secondary 
character". 
Another definition of secondary metabolites was really a set of observations 
and does not address their origin and function. Secondary metabolites were defined 
as "those metabolites which are often produced in a phase subsequent to growth, have 
no function in growth (although they may have a survival function), are produced by 
certain taxonomic groups of organisms, have unu · al chemical structures, and are 
often formed as a mixture of closely related members of a chemical family. "9 In 
5 
microorganisms, those metabolites which are not essential for growth of the 
producing culture but serve diverse survival functions are also termed "idiolites". 8 
A more pragmatic definition of a secondary metabolite by Williams 10 is "a 
naturally produced substance which does not play an explicit role in the economy of 
the organism that produces it". 
The different definitions mentioned have all been considered in the 
following widely accepted definition of a secondary metabolite - "a metabolic 
intermediate or product found as a differentiation product in restricted taxonomic 
groups , not essential to growth and life of the producing organism, and 
biosynthesized from one or more general metabolites by a wide variety of pathways 
than is available in general metabolism" .s 
For the purposes of this report, the term natural products will be equated to 
secondary metabolites. Those two terms will be used interchangeably while keeping 
in mind the proper definition of each. 
B. Role and Origin 
The definitions of secondary metabolites outlined above do not imply the 
origin and functions of these compounds and even researchers in the field usually 
have conflicting views about them. However, there are several features of secondary 
metabolism that are no longer matters of speculation according to Vining. 11 
These are: 
1. Secondary metabolites are not essential for growth and tend to be strain 
specific. 
2. They have a wide range of chemical structures and biological activities. 
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3. They are derived by unique biosynthetic pathways from pnmary 
intermediates and metabolites. These pathways are often long and 
complex; the reactions are catalyzed by enzymes with substrate 
specificities different from those of primary metabolism. 
4. The formation of secondary metabolites is directed by an organized set of 
genes associated with special regulatory mechanisms that seem to control 
both the timing and level of gene expression. 
5. The control mechanisms are well integrated with the physiology of the 
producing organism. 
The most current views on the functions of secondary metabolites can be 
narrowed to two themes.11 They are seen to serve a purpose within the producing 
species such as being involved in the mediation of growth, reproduction or 
differentiation. They also act on targets external to the producer which include the 
many antibiotics, mycotoxins, insecticides, and herbicides. A secondary metabolite 
can therefore improve the evolutionary fitness of the producer either by having an 
adverse effect on a competitor, or by helping to engage a second organism in an 
activity which is advantageous to the producer.12 
It is also worth noting that secondary metabolites are usually produced by 
bacteria, algae, corals, sponges, plants and lower animals, and very infrequently 
biosynthesized by higher animals. That is, secondary metabolites are common in 
organisms that lack an immune system, whereas they are sparse in organisms which 
possess an immune system. This implies that the production of secondary 
metabolites increases the organism's fitness for survival in the former case, acting as 
an alternative (chemical) defense mechanism.IO 
The diversity of secondary metabolites can be accounted for by the selective 
influence of environment, both physiological and ecological , associated with the 
organism in which the secondary metabolic pathway has evolved.13 Their production 
7 
may be enhanced or reduced by many abiotic factors such as seasonality, levels of 
macro- and micronutrients, osmotic stresses and light intensity .14 
In microorganisms for example, the more prolific microbial groups are those 
inhabiting resource-rich environments since survival requires that a species compete 
successfully with numerous others, each of which may be similarly or better 
endowed. Most of the known antibiotic-producing organisms have therefore been 
isolated from the soil where a large variety of antagonistic organisms is present.13 
Competition has probably selected for strains able to promote their own survival by 
excreting toxic metabolites including the antibiotics penicillin (5), carbapenems (6) 
and monobactams (e.g., 7). 
Penicillin ( 5) 
0 
H 
N 
OH 
H 
0 
0 
Monobactam (7) 
~NH2 
Carbapenems ( 6) 
QCH3 
-
-
' 
Aside from antibiotics, there has been new evidence that among the 
metabolites of microorganisms are found compounds that will have applications as 
therapeutic agents14 such as immunomodulators, inhibitors of cell proliferation and 
some agricultural products. 
In plants, there is ample evidence that many secondary metabolites feature 
significantly in a plant's interaction with its own natural habitat. In indigenous plant 
communities, secondary metabolites from particular plants affect the growth of other 
8 
plants in the same area, and may determine the distribution patterns of plants and 
their ecology. The word allelopathy has been generally adopted as the term to 
describe this phenomenon and "allelochemicals" the substances that mediate these 
interactions. 15 Some examples are the simple phenolics p-coumaric acid (8), ferulic 
acid (9) and p-hydroxybenzoic acid (10) which are contained in the leachate of 
Adenostoma f asciculatum leaves and retard the growth of seedlings under the mature 
bush. 
OCH 3 
OH OH OH 
p-Coumaric acid (8) Ferulic acid (9) p- Hydroxybenzoic acid (10) 
Secondary metabolites also act as a defence against predators and 
pathogens.16 Pyrrolizidine alkaloids such as senecionine (11) are active in deterring 
mammalian herbivores and terpene derivatives such as pyrethrin-1 (12) act as insect 
anti-feedants. Phytoalexins such as pisatin (13) are formed de novo in response to 
attack by pathogens. 
0 
0 
H 0 
II 
c, , 
o' 
---N---
Senecionine (11) Pyrethrin-1 (12) 
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0 0 
Pisatin (13) 
For the plant's survival and evolution, various compounds are produced to 
attract a vast range of potential pollinators and seed dispersal agents such as bees, 
butterflies, birds, etc.16 For visual stimuli, the most common metabolites are the 
flavonoids, which include the anthocyanins, flavonols, aurones, chalcones, 
flavanones, flavones and flavanols. Another route to attraction used by plants is 
olfactory. This is attributed to the production of low molecular weight terpenes 
(mono- and sesquiterpenes), simple benzoic and cinnamic acid derivatives and long-
chain alkanes, alkanols and alkanals. The third chemical strategy for attracting 
pollinators is nectar-production due mainly to simple sugars, and sometimes amino 
acids and/or lipids. Secondary metabolites that are harmless to nectar-feeders but 
toxic to other animals or insects can also be present in the nectar. 
Among insect herbivores, the ability to acquire and store bioactive plant 
chemicals can sometimes develop. These secondary metabolites are then adapted to 
the insect's own communication and defence systems. 17 The pyrrolizidine alkaloids 
are a good example of compounds which are used by the cinnabar moth Tyria 
jacobaeae as protection against birds, while in Lepidoptera such as the Acraeinae 
butterflies the alkaloids are used as precursors for male pheromone production. 
Secondary metabolites are also produced by insects. In the ant Leptogenys diminuta , 
the monoterpenoid cis-isogeraniol (14) is biosynthesized and has been recognized as 
an important recruitment pheromone, while geraniol (15) is known to be a trail 
pheromone of the honey bee. 
10 
CH3 CH3 
H3C OH 
cis-Isogeraniol (14) Geraniol (15) 
In algae and manne organisms, most structural features of secondary 
metabolites are similar to those of terrestial counterparts.18 There are some chemical 
features though which are quite characteristic of marine organisms such as the 
presence of halogens, isonitriles, isothiocyanates, or peroxy substituents. Many of 
the compounds have potent bioactivities as toxins or as therapeutic agents such as 
manoalide (16) from the sponge Luffariella variabilis which is used in exploring 
physiological processes implicating the phospho!ipase A2 (PLA2) inactivation. 19 
Manoalide (16) OH 
However, little is known about the role of marine secondary metabolites in 
their natural environment, that is, in functions such as inhibiting predation, providing 
competition or marking trails. 20 
The remarkable diversity of the biological functions and chemical structures 
of secondary metabolites initially led researchers to believe that this reflected the 
random manner in which their biosynthesis had evolved and been exploited. It was 
considered that the secondary pathways represent adaptive extensions of the pre-
existing metabolic apparatus, presumed to be the essential primary pathways that 
supported normal life functions in ancestral organisms.21 Suggestions that secondary 
metabolites are "facilitating" molecules and are not "function-defining", and that their 
> 
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present-day biological activities are likely to be some manifestation of the 
evolutionary functions22, do not, however, seem to be consistent with the 
sophisticated structures, activities and mechanisms of actions of these compounds. 
That these specializations are not due to accidental fits has led to the conclusion23 
that secondary metabolite structures have been honed, by selectional pressures, to 
bind at receptor sites in organisms which compete with the producers. 
C. Screening 
The assumption that no secondary metabolites are biologically inert might be 
difficult to prove. However, in recent years, the impression that many secondary 
metabolites, especially those isolated fortuitously by chemists or discovered in non-
selective screening, are biologically inactive has been modified by evidence that such 
products commonly give positive responses when subjected to wide-spectrum 
biological testing. Targeted screening procedures have also identified substances 
previously thought to be biologically inactive.11 This shows how important screening 
procedures are in the study of natural products. 
The choice of starting material, whether plant or animal, for the extraction 
and purification of compounds with the desired biological activity is always the first 
and main consideration in any natural products study. In plant selection, approaches 
include selections based on ethnotherapeutic and folkloric considerations, botanical 
or phytochemical considerations and random choice. 24 
Folk medicine targets a selective group of plants that have centuries of 
human experience on their side. Its practice is based mainly on traditional beliefs 
handed down from generation to generation and is an integral part of each culture. 
They sometimes result in activities different from those attributed to them, but they 
are nevertheless useful leads. 
12 
The use of chemotaxonomic knowledge can also be used since it is a fact 
that there is a degree of predictability in the distribution of natural products in nature. 
This may be used in the search for new compounds or in trying to extend the range of 
structures of a given kind that are available for study. Observations of the plant's 
natural defenses can also direct in a specific manner the search for compounds that 
will be of interest to the agrochemical industry or more generally as antibiotics. 
Bioassay-guided screening can also lead to the choice of plant for extraction. 
One can run plant extracts more or less at random through specific screens until one 
gets positive results to different bioassays. 25 And serendipity is still sometimes 
practiced by inquisitive chemists working without any realistic goal beyond 
characterization. This often results in interesting compounds even without known 
bioactivity, and is still considered a good training ground for postgraduate students. 
One of the hazards in such study is the possibility that some of the compounds 
isolated will have some toxicity. 
The selection of the most appropriate assays for bioactivity-guided screening · 
is very important. These bioassays are usually characterized by sufficient specificity 
to exclude a great variety of inactive constituents and sensitivity to detect a minute 
amount of active components in the crude extracts.4 A high throughput26 is also 
desirable so that a large number of samples can be processed in a short time to make 
sure that decomposition or other time-related factors do not affect the validity of the 
assay. 
There are two main types of bioassays that are commonly used to screen 
secondary metabolites. The first is usually called a bench-type bioassay27 and 
include the brine shrimp lethality test (for cytotoxicity), inhibition of crown gall 
tumors on potato discs (an anti-tumor bioassay), and monitoring of frond proliferation 
in Lemna or duckweed (a bioassay for herbicides and plant growth stimulants). 
These are inexpensive, simple enough for phytochemists to use, yet have been found 
effective for the isolation of bioactive compounds. 
13 
The second type is the sophisticated, target-directed, mode of action bioassay 
using chromogenic substrates, radioligands, immunoassays, microtiter systems and 
animal models. With advances in the understanding of disease processes at the 
biochemical and genetic levels, cellular enzymes or receptors as targets for 
therapeutic intervention are being designed. Recombinant DNA technology and 
modem cell biology can also provide the tools for the development of more screening 
methodologies based upon different mechanisms of action.14 
D. Future Prospects 
The developments of more practical screening methodologies based upon 
mechanism of action means that natural products can be screened for defined 
biological activities. More sensitive and selective bioassays , bioautography and 
radioimmunoassays can result in the isolation of bioactive compounds which are 
present in minute quantities in complex mixtures . 
Isolation of small amounts of natural products can be accomplished using 
modem chromatography techniques. Examples* are countercurrent chromatography 
such as DCCC and RLCC, newer planar chromatography methods like OPLC and 
CTLC, column chromatography including gel chromatography, FC and VLC, and 
pressure liquid chromatography such as low- , medium- and high pressure liquid 
chromatography. Structural studies at the µg level can be carried out using different 
mass spectrometric ionization techniques such as EI, CI, FAB , electrospray and 
MALDI together with high resolution mass measurement and tandem mass 
spectrometry (MS/MS). 
Modern pulse techniques in high field nuclear magnetic resonance 
spectroscopy28 can also provide more information on metabolites that may be isolated 
in larger amounts. The advent of 600 MHz instruments has resulted in increased 
* Abbreviations and acronyms are defined on page v. 
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resolution of lD 1 H NMR spectra which simplifies and facilitates the analysis of 
formerly complex spectral regions. lD experiments that can be carried out include 
DEPT to determine the multiplicities of various carbon atoms while nOe experiments 
can give information on spatial proximity of nuclei which can help establish the 
relative stereochemistry of different groups in the molecule. Other useful 
experiments are the 2D NMR homo- and heteronuclear correlation direct-detection 
methods such as COSY, NOESY, HETCOR, long-range HETCOR and 
INADEQUATE when enough quantity of sample is available. If there are sample 
quantity limitations, homonuclear and heteronuclear correlations can still be obtained 
using inverse detection (i .e. transfer of 13C magnetization to 1 H nuclei prior to 
detection) such as in HMBC and HMQC experiments. Further confirmation of 
structures can then be obtained using relayed magnetization transfer experiments such 
asHOHAHA. 
The development of three-dimensional (3D) and four-dimensional ( 4D) 
NMR techniques which are in principle a combination of 2D techniques can also be 
very useful in elucidating structures of larger molecules. These techniques are now 
being used29 for the structure determination of peptides and proteins with molecular 
weights <35 kDa, and the increased resolution obtained in multidimensional NMR 
spectroscopy will be very valuable in assigning structures of more complex 
secondary metabolites. 
Another future prospect is in the use of cell cultures in natural products 
studies. There have been problems associated with the natural products production 
using plant cell cultures. Morphological specialization is suppressed in plant cell 
cultures, and with it, in many cases, most of the chemical specialization appears to be 
lost. 15 However, plant cell culture methods can still afford interesting routes to 
biologically active compounds.6 Biosynthetic information can be gleaned from cell 
cultures which can form a basis for efficient synthesis of complex natural products. 
The enzyme systems in a developed culture can also be used as reagents to 
biotransform precursors to suitable end products. By nutrient media changes, one 
15 
may also be able to produce novel metabolites which are not found in plant extracts. 
The separation of pharmacological activities in complex herbal medicinal extracts can 
also be achieved. 
Advances in molecular biology and biotechnology may help identify and 
characterize the multiple enzymes involved in the complex biosynthetic pathways for 
the genetic engineering of secondary metabolites. It is currently a difficult task, but 
in the immediate future, the technology may gain importance in the preservation of 
species threatened by extinction, which includes medicinal plants.30 
The above mentioned prospects in natural products chemistry can be better 
achieved by a more interdisciplinary approach towards the search for bioactive 
compounds. 
E. Current Research Work 
The work that will be discussed in the following three chapters involves the 
isolation, purification and structure elucidation of secondary metabolites from several 
plants which have been selected based on ethnotherapeutic and phytochemical 
considerations. 
The study on Eupatorium adenophorum was initiated because of its close 
relation with Eupatorium rugosum which has been recognized as the etiologic agent 
responsible for milk sickness in humans and trembles in animals. 31 The bioassay-
guided isolation of the bioactive compounds was conducted by Dr. Peter Oelrichs 
from the Animal Research Institute in Queensland and the structure elucidation of 
those components was carried out in this laboratory. 
The second plant studied was Wedelia asperrima Benth. , a toxic shrub which 
has been responsible for sheep losses in northwestern Queensland. From previous 
studies,32, 33 the diterpene aminoglycoside wedeloside (WED, 17) has been reported 
16 
to be the major toxic component. It acts as a powerful inhibitor of ADP/ ATP 
transport across the mitochondrial membrane34 with a binding affinity similar to a 
related diterpene glycoside, carboxyatractyloside (CATR, 18)35. This study was part 
of a continuing search for the isolation of toxic and non-toxic compounds related to 
wedeloside in order to study structure-activity relationships. 
0 
0 
W edeloside (WED) 
(17) 
0 
Carboxyatractyloside (CATR) 
(18) 
. 
• .. , 
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The third plant investigated was Wedelia prostata. It was expected on 
chemotaxonomic grounds that it may contain compounds related to those (e.g. 
wedeloside) in W. asperrima. However, this plant has been used in traditional 
medicine in the Philippines without any reported cases of poisoning which suggested 
the absence of any toxic components. This chemical investigation was undertaken to 
determine the structures of possible pharmacologically active metabolites , including 
wedeloside analogues, that were present in the plant. 
' I t 
CHAPTER II 
BIOLOGICALLY ACTIVE 
COMPOUNDS FROM 
EUPATORIUMADENOPHORUM 
SPRENG. 
... 
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A. Introduction 
Eupatorium adenophorum Spreng. (Compositae ), commonly known as 
crofton weed, is an asteraceous plant native to Central America but has spread to 
Australia along the eastern seaboard from northeastern New South Wales to 
southeastern Queensland.36 The plant is also synonymous with Ageratina 
adenophora (Spreng.) R. King and H. Robinson37 and E. glandulosum H. B. and 
K.38. 
Interest in the plant was due to its close relationship with E. rugosum Houtt 
(white snakeroot, synonymous with E. urticaefolium and Ageratina altissima L.) 
found in the U.S.A., which is recognized as the etiologic agent responsible for the 
diseases "milk sickness" in humans and "trembles" in animals.39 Many attempts have 
been made to isolate and identify the active compound(s) from white snakeroot, but 
until recently no conclusive evidence for any specific active principle or its 
mechanism of action has been reported. Recent results40 from in vitro bioactivity 
assay isolation showed that the ketone tremetone (19) is the major toxic component in 
white snakeroot. Microsomal activation of tremetone is suspected of producing 
metabolites that are responsible for the toxic activity of the plant. 
0 
Tremetone 
(19) 
E. adenophorum, on the other hand, has been recognized as a cause of 
chronic respiratory diseases in horses in Australia, New Zealand and Hawaii. The 
disease is characterized by pulmonary fibrosis, emphysema, alveolar epithelialization 
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and markedly reduced exercise tolerance.41 Feeding experiments (10-15g green 
plant/kg live weight over several months) have reproduced the same irreversible 
condition with horses but did not affect other species of domestic animals.42 
Studies in which crofton weed was included in the diet of mice have shown 
that lesions occur in the liver rather than the lungs.43 One single dose (lOOmg/kg) of 
the powdered leaf was found to be sufficient to produce damage to the small intra-
hepatic bile ducts. The lesions observed suggested that the injury was due to regional 
escape of irritant bile through damaged bile. duct walls into the surrounding tissues. 
Another feature of the necrotic foci was their persistence for as long as 50 days 
despite the removal of the plant from the diet of the mice for the last 15 days. The 
relationship of this lesion in the mouse liver to the chronic respiratory lesion in the 
horse caused by the plant, as well as to the original milk sickness syndrome caused by 
E. rugosum, is still unclear. It is hoped to study these effects further to determine if 
they are related.44 
Chemical investigations of the plant have led to the isolation of the flavonol 
glycoside (20) and the cadinene (21). The flavonol glycoside (20) was initially 
considered as a possible active principle since it showed a low level of toxicity in a 
mouse assay. However, a more specific bioactivity assay-guided isolation later 
confirmed that the cadinene (21) is the toxic compound in crofton weed that causes 
damage to the small intra-hepatic bile ducts in mice.45 
0 
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9-0xo-10, 11-dehydroageraphorone 
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This section discusses the identification of compounds (20) and (21), which 
was carried out using UV, IR, high field 1 H and 13C NMR spectroscopy and mass 
spectrometry, their comparison with similar known compounds and derivatization. 
B. Flavonol Glycoside 
1. Occurrence and Function 
The flavonol glycosides belong to a large group of naturally occurring 
polyphenolic compounds called flavonoids which are characterized by a C6-C3-C6 
carbon skeleton system. The structural features of some of the major classes of 
flavonoids and their numbering pattern are shown in Figure 2. I .46, 47, 48 
Natural flavonoids are usually oxygenated and bear hydroxy or methoxy 
substituents. Many are present in plants as 0-glycosides in which one ( or more) of 
the hydroxy groups is bonded to a sugar moiety via an acid-labile .acetal bond. 
In flavonoid C-glycosides, the sugar is C-linked and this linkage is acid-resistant. 
The effect of glycosylation is to render the flavonoids less reactive and more water 
soluble which is why they are usually found in the plant cell sap. 
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OH 
HO 
OH 
R-1 R2 Other 
Flavanone H C=O 
3-Hydroxyflavanone OH C=O 
Flavan-3-ol OH CH2 
Flavone H C=O C2=C3 
Flavonol OH C=O C2=C3 
Anthocyanidin CH2or 01=C2 C3=C4 
' ' 
CHOH positive charge on Cring 
Figure 2.1. Basic flavonoid molecule with 5,7-hydroxylation pattern of the A ring 
and 2S -stereochemistry. Variations of Rl, R2, etc. are tabulated. 
Some flavonoids have sulfates attached to the hydroxy 1 group of the 
flavonoid or the sugar portion. They can also exist as dimers while others can have 
additional carbon atoms in their flavonoid skeleton such as in anthocyanidins. 
Aside from glycosides , flavonoids have also been found as the free 
aglycones in various plants. In most cases , these have been correlated with the 
presence of secretory structures, essential oils and similar lipophilic secondary 
products.48 
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The most frequently documented function of the flavonoids in the plants is 
L;-7 
as filter against UV-A(< 280 nm) and UV-B (280-320 nm) radiation. It has been 
argued47 that they may also function as internal physiological regulators or chemical 
messengers and serve as signals to outside organisms, permitting the evolution of 
mycorrhizal and nitrogen-fixing relationships. In addition, they have evolved as 
effective means of chemical defence against microorganisms and herbivores, though 
some can function as attractants in angiosperm pollination and seed dispersal. 
In industry, the flavonoids have uses in the tanning of leather, fermentation 
of tea, manufacture of cocoa, flavoring of foodstuffs and in forest products 
processing. In addition to these, the flavonoids have been found to have a wide array 
of biological activities49 which include anti-inflammatory effects , effects on central 
vascular system, antitumor activity,50, 51 antimicrobial and antiviral activity,52, 53, 54 
cytotoxicity, 55 antioxidants, and other activities such as anti-allergenic, anti ulcer, 
analgesic, antimalarial and hypoglycaemic. This broad spectrum of bioactivity of 
flavonoids and the multiplicity of actions of certain compounds has led to a large 
research output on this group of compounds. 
2. Biogenesis 
Ample evidence has been presented that at least part and probably the entire 
pathway of flavonoid biosynthesis is membrane-associated and the metabolism 
facilitated by a multi-enzyme complex.56 The flavonoid biosynthesis has its mixed 
origin from the malonyl CoA and shikimate pathways. The B-ring comes from the 
phenylalanine and 4-coumaric acid precursors (Scheme 2.1 ), while the benzyloxy 
(ring A) system arises from malonyl CoA units. 
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Scheme 2.1. 4-Coumaric acid biosynthesis S? 
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Scheme 2.2. Flavonol biogenesis 57 
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The initial step (Scheme 2.2)57 leading to the C15 flavonoid skeleton such as 
in naringenin chalcone, is a condensation reaction of 4-coumaroyl CoA and three 
malonyl CoA units catalyzed by the enzyme chalcone synthase. Cyclization of the 
chalcone to 2S-flavanone is proposed to be a general acid-base mechanism (Figure 
2.2), catalyzed by the enzyme chalcone isomerase. The 2S-flavanone is then 
hydroxylated to the 2R,3R-dihydroflavonol (flavan-3-ol) in the presence of co-factors 
2-oxoglutarate, oxygen, Fe2+ and ascorbate catalyzed by 3P-hydroxylase. 
Conversion of the flavan-3-ol to the flavonol kaempferol is catalyzed by a related 2-
oxoglutarate/ oxygen/ ascorbate/ Fe2+ dependent enzyme, flavonol synthase. The 
formation of diverse hydroxylated, 0-methylated and glycosylated flavonoids has 
been attributed to the action of several hydroxylases, 0-methyltransferases and 
glycosyltransferases on the initial flavonoid nucleus.58 
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Figure 2.2. Chalcone-flavanone isomerization 
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Plant collection, extraction and isolation of the compound were carried out 
by Dr. Peter Oelrichs in Brisbane. The sample supplied by Oelrichs was further 
purified by dissolving in the upper layer of 13:8:4 chloroform-methanol-water 
mixture and extracting with the lower layer of the solvent system. The pure 
compound was obtained as a yellow solid melting at 148-151 °C. 
The positive and negative FAB mass spectra of the compound showed 
prominent ions corresponding to a molecular mass of 492, at m/z 493 MH+ and m/z 
491 [(M-H)-J respectively. These showed a loss of 162 mass units to give ions at mlz 
331 and 329, confirming the presence of a hexose unit. EIMS showed a prominent 
ion for the aglycone at mlz 330 which by accurate mass measurement gave C17H1407 
as its formula. Together with the C6-glycoside, C6H 1 oO 5, this added up to a 
molecular formula of C23H24012. 
From the UV spectral data of the compound in MeOH and upon addition of 
different reagents (Table 2.1), it was deduced that the compound was a flavonoid 
glycoside.59, 60 The · ~ max of 341nm in MeOH is usually characteristic of the B-ring 
absorption (Band I) of a flavonol which is either 3-methoxylated or glycosylated, as 
compared to a flavonol with a free 3-0H group which usually absorbs at a longer 
wavelength (352-385 nm). 
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Addition of NaOMe, a strong base that ionizes all the hydroxy groups in a 
flavonoid, resulted in the bathochromic shift (56 nm) of Band I without a decrease in 
60 
the intensity of the peak, which indicated the presence of a 4'-0H group. The 
presence of this hydroxyl group was further confirmed by the shoulder on the long 
wavelength side of Band I observed upon addition of the weaker base, NaOAc, to the 
methanolic solution. This did not result in any bathochromic shift of band II which 
60 
implied the absence of a free 7-0H substituent. 
Table 2.1. UV Spectral data of compound (20) 
Amax (nm) 
Band I (Bring absorption) Band II (A ring absorption) 
MeOH 341 271 
MeOH+NaOMe 397 272 
MeOH+NaOAc 408sh, 354 271 
MeOH + NaOAc+ H3B03 344 271 
MeOH +AlCb 364 278 
MeOH + AlCl3 + HCl 361 280 
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The methanolic mixture with boric acid in the presence of N aOAc did not 
result in any significant change in the UV spectrum which was indicative of the 
60 
absence of an ortho di-OH function in either A or B ring. Addition of AlCl3 to the 
methanolic solution can also be used to determine the presence or otherwise of an 
ortho di-OH function as well as a free 3-0H or 5-0H, since it can form a complex 
with the aforementioned functional groups (Scheme 2.3). The AlCl3 complex with 
the ortho di-OH groups can be decomposed by addition of a strong acid such as HCl 
6o 
without affecting its complex with the carbonyl and 5-0H (or 3-0H). From Table 
2.1, it could be deduced that the bathochromic shift (21 nm) observed after addition 
of AlCl3 was due to the presence of a free 5-0H group since other UV evidence had 
shown that there was no free 3-0H group. The lack of any change in the spectrum 
after addition of the HCl confirmed the absence of any ortho di-OH substituents. 
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Scheme 2.3. AlClrflavonoid complex 
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From the UV and mass spectral data, it was proposed that the compound had 
the general structure (22). The structure with a free 4'-0H group was supported by 
the observation of an ion at m/z 121 in the EI mass spectrum corresponding to the B + 
fragment which is a characteristic ion produced from ionization of flavonol and its 
derivatives61 as shown in Figure 2.3. 
0 
OH 
0 
... 
~c 0 :;.,, 
B+ fragment 
Figure 2.3. Characteristic B ring ion formed from 
mass spectral fragmentation of flavonol 
+ 
OH 
The 1 H NMR spectrum (Table 2.2) exhibited two methoxy signals at 83 . 90 
and 83.75. The doublet at 85.44 (J 8Hz) was indicative of the anomeric proton of a 
~-linked hexose. The other signals showed the two sets of equivalent protons ortho 
to each other at 86.87 for H-3 ' and H-5' (J 9Hz) and at 88 .11 for H-2' and H-6 ' (J 
9Hz). The singlet at 86.90 was tentatively assigned to H-8. 
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Table 2.2. 1 H NMR chemical shifts of compound (20? and acetylated derivative 
H Compound (20) Acetylated derivative (25) 
8 6.90 (s) 6.88 (s) 
2' 8.ll(d,19) 8.08 (d, J 9) 
3' 6.87 (d, J 9) 7.2l(d,]9) 
5' 6.87 (d, J 9) 7.21 (d, J 9) 
6' 8.ll(d,]9) 8.08 (d, J 9) 
1" 5.44 (d, J 8) 5.50 (d, J 8) 
2"-6"C 3.55 H-2", 3.38 H-3", 3.66 H-4", 5.06-5.40 (m) 
3.34 H-5 '': 3.46 H-6" 
6-0CH3 3.75 (s) 3.86 (s) 
7-0CH3 3.90 (s) 3.99 (s) 
OAc - 1.92 (s), 1.99 (s), 2.12 (s), 
2.14 (s), 2.34 (s), 2.50 (s) 
a 8 from 2.49 in d6-DMS0 at 300 MHz. Multiplicity and coupling constants J (Hz) 
in parentheses. 
b 8 from TMS in CDCb at 300 MHz. 
c Signals of the glycosidic protons of (20) overlapped but assignment was based on 
HETCOR (Figure 2.4). 
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Comparison of the Be NMR spectrum (Table 2.3) with related compounds62 
led to the proposed structure (20). The signal at 101.6 ppm is in agreement with 
chemical shift for the anomeric carbon of an 0-linked ~-D-galactopyranoside, and the 
other signals between 60 ppm and 76 ppm fit closely the signals for C-2 to C-6 of a 
galactopyranoside rather than any other hexopyranoside. The C-H assignments were 
obtained from the HETCOR spectrum shown in Figure 2.4. 
The chemical shift of C-3 as well as those of C-2 and C-4 were indicative of 
0-glycosylation at C-3.63 Flavonols with a free 3-0H usually have carbon signals at 
135.5 ppm but 0-glycosylation resulted in an upfield shift of -2 ppm to 133.3 ppm. 
This also produced an "ortho"-related effect at C-2 (signal usually at 147 ppm) 
resulting in a large downfield shift of 9.5 ppm. 
The substitution pattern on ring A was also confirmed from the 13C NMR 
data. For flavonols unsubstituted at C-6, its signal is observed at 98 ppm but 
methoxylation caused a downfield shift to 132 ppm. This also affected the C-7 signal 
which is usually at 164 ppm but substitution at C-6 caused it to shift upfield to 159 
ppm while the C-9 signal shifted from I60 ppm to 152 ppm. The two aromatic 
methoxyl groups with chemical shifts 60.2 ppm and 56.7 ppm were assigned to 6-
0Me and 7-0Me respectively with the former, being ortho to two electron-releasing 
groups, shifted further downfield. 
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T bl 2 3 13C NMR a e d (20)a d (23)b t t ass1gnmen s or compoun s an 
C (20) (23) C (20) (23) 
2 156.9 160.00 1' 121.0 120.8 
3 133.3 133.3 2' 131.2 131.0 
-
4 178.0 177.8 3' 115.2 115.1 
5 151.8 151.6 4' 160.2 158.7 
6 131.8 131.8 5' 115.2 115.1 
7 158.8 156.8 6' 131.2 131.0 
8 91.5 91.3 1" 101.6 101.7 
9 151.9 151.8 2" 71.4 71.2 
10 105.5 105.3 3 II 73.2 73 .1 
6-0Me 60.2 60.2 4" 68.1 67.9 
OMe 56.7 (C-7) 56.5 (C-4') 5" 76.0 75 .7 
6" 60.4 60.2 
a 8, in ppm from 39.5 in d6-DMSO at 75.43 MHz. 
b Broad band decoupled, 67.89 MHz, 8 ppm, d6-DMSO, TMS intemal.64 
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Figure 2.4. HETCOR spectrum of compound (20) 
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A literature search showed that a related structure (23) had been proposed by 
Ramachandran Nair et. al. in 199064 for a compound isolated from E. glandulosum H. 
B. and K.. This plant name is synonymous with E. adenophorum. Their proposed 
structure (23) was established from spectroscopic data (UV, lH and 13C NMR, MS), 
acetylation and co-chromatography of the aglycone with an authentic sample of 
betuletol (24). 
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Close examination of their data (for 13C NMR, see Table 2.3) revealed that 
they were virtually identical to those obtained for (20), and differed only in the 
assignment of the chemical shifts of C-2, C-7 and C-4'. Under the circumstances, it 
seemed reasonable to assume that both compounds had the same structure. To 
confirm that structure (20) was the correct one, acetylation was carried out to 
distinguish H-3', H-5' from H-8, all with chemical signals around 86.9, and show their 
possible correlation with the methoxyl groups and other carbon atoms in the ring. 
Long range HETCOR of the original sample did not show a clear correlation of the 
above protons with the carbon atoms of rings A and B because of the proton signal 
overlap. 
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The 1 H NMR of the acetylated compound (25) (Table 2.2) showed a 
downfield shift of the H-3' and H-5' signals which implied the acetylation of a 
formerly free 4'-0H group. The spectrum of the acetate was identical to that reported 
by Ramachandran Nair. 64 The long range HETCOR also showed a clear correlation 
of the two methoxy signals with C-6 and C-7 which are in turn correlated to H-8 
(Figure 2.5). The absence of long range correlation of any of the methoxy protons 
with the carbon atoms in ring B further confirmed that both methoxy groups were in 
ring A. This verified that the correct structure for the compound was (20) and not 
(23) as earlier proposed64. 
A review of the literature showed that a compound which was assigned 
structure (20) had been isolated previously during chemotaxonomic studies of the 
genus Brickellia (Tribe Eupatoriae, Family Compositae). It was first reported by 
Mabry et. al. in 198065 from Brickellia dentata (D. C.) Sch. Bip. and was named 
eupalitin-3-0-galactoside. Their evidence for its structure was based on the TLC, 
UV, 1 H NMR of the TMSi derivative and MS data, and comparison of the hydrolysis 
products with standard samples of galactose and eupalitin. Since then, the compound 
has been reported in Brickellia monocephala, 66 Ageratina calophylla67 and E. 
areolare var. leiocarpum68. Unfortunately, no 13C or 2D NMR data are available 
which might confirm that the compound they isolated is identical to the compound 
from E. adenophorum. Their chemotaxonomic studies showed that the flavonoids in 
the tribe Eupatoriae have an ancestral chemical pattern based on 6,7-dimethoxylation 
which agrees well with the structure (20). 
There has been no pharmacological activity reported for the compound (20), 
except that by Ramachandran Nair for the compound they isolated, designated as 
(23), which has been found to have analgesic activity in mice and rats.69 
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36 
37 
B. Cadinene 
1. Chemistry and Distribution 
Cadinenes belong to a large group of compounds called terpenes, which are 
compounds derived biogenetically from isoprene (2-methylbutadiene, 25) units.70 
Depending on the number of isoprene units used as building blocks in the structure, 
terpenes are subdivided into hemi-, mono-, sesqui-, di-, and triterpenes which contain 
one, two, three, four and six isoprene units respectively. Cadinenes which have 15 
carbon atoms can then be further classified as a sesquiterpene. Sesquiterpenes can be 
aliphatic, cyclic and may contain different functional groups. They may be saturated 
or unsaturated, and can have hydroxy, oxo, carboxylic or lactone groups. 
Isoprene (25) 
Sesquiterpenes are usually volatile and lipophilic plant constituents, although 
a limited number of insects and microorganisms also produce them. They are often 
components of essential oils which are used in medicine or are of commercial 
value.70 They may also dominate the scents of flowers to attract pollinators, and may 
contribute to the scents and tastes of spices and foodstuffs. In some plants, they can 
serve as defense chemicals, while in insects they can function as hormones. 
Several sesquiterpenes have been previously isolated from E. adenophorum. 
Examples are eupatorenone (26)37 which has an unsaturated azulene skeleton, and 
(27) 71 , one of a number of sesquiterpenes of the cadinane-type, which has been 
reported to exhibit appreciable anti-feedant action against 4th-instar caterpillars of the 
Eri-Silk worm (Philasomia ricini Hutt).72 
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It has been established that sesquiterpenes originate biogenetically from 
isopentenyl diphosphate which is formed from acetyl CoA.70 The isopentenyl 
di phosphate then undergoes nucleophilic substitution at C-1 (tail of the molecule), 
and electrophilic substitution at the double bond (head of the molecule), and can 
undergo head-to-tail condensation to form consequently farnesyl diphosphate 
(Scheme 2.4). 
The mechanisms and enzymes involved in the cyclization of farnesyl 
diphosphate to form the numerous skeletal types of the sesquiterpene group is not 
well understood.73 Different incorporation experiments with 14C from CO2, acetate 
and mevalonate into a variety of sesquiterpenes in pine (Pinus pinaster) indicated that 
detailed mechanisms for various classes of products differ for the individual 
precursors.74 However, it has been suggested46 that for the cadinane-types, the cation 
(28), formed from the loss of the d, phosphate anion, can then undergo 
rearrangement and cyclization to form the cadinene skeleton. The initially formed 
cyclization product can be generated as an olefin or simple alcohol or an ether 
derivative. These maybe subsequently transformed by oxidation or occasionally by 
carbon-carbon bond cleavage to give rise to the vast number of functionalized 
sesquiterpenes. 
3 CH3CO-CoA 
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Cadinol ( cadinane) 
... 
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The bioactive compound (21) was obtained as an oil from a bioassay 
directed isolation carried out by Dr. Peter Oelrichs and exhibited a molecular ion at 
m/z 232 which mass measured for C1sH2o02. In the IR spectrum, a strong absorption 
at 1675 cm- 1 suggested the presence of the a,~-unsaturated ketone functionality. 
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The lH NMR spectrum of (21) in CDCl3 (Table 2.4) showed one olefinic 
proton at 86.24 and both aliphatic (80.99) and allylic (81.73 dd, 1.91 s, 2.02 s) methyl 
groups. The presence of the four methyl signals suggested that the compound could 
be a sesquiterpene. Two sets of geminally coupled methylene groups (82.43, 2.15 
lgem10.8Hz and 82.63, 2.83 lgem 16Hz) were also indicated for the molecule. 
The 13C NMR and DEPT spectra showed five quaternary carbon atoms, two 
of which were ketone functionalities (197.6, 202.6 ppm) and the remaining three were 
unsaturated carbons (134.1, 135.7, 143.5 ppm). There were four methyl groups with 
chemical '$h\f1s at 15.2, 19.4, 21.8, 22.9 ppm and two methylene carbons (41.3, 50.4 
ppm). The above data supported a cadinene skeleton for the compound having two 
a,~-unsaturated ketone functionalities with three of the vinylic carbons possessing 
methyl substituents. From the chemical shifts of the two methylene groups, it could 
also be inferred that they were adjacent to the ketone functionalities. 
To assign unambiguously the positions of the methine protons, the NMR of 
the sample was recorded in C6D6 which gave a spectrum with a better separation of 
the proton signals. 1 H NMR in C6D6 and DQF-COSY showed that the olefinic 
proton H-4 (85.82) is coupled to H-5 (83.56, -J 2 Hz). The small J value indicated 
that the dihedral angle between the two protons is close to 90° and meant that H-5 
must be equatorial. H-5 is further coupled to H-6 (81.52, -J 5 Hz) which showed that 
H-6 is axial. The large value (J 10 Hz) of coupling between H-6 and H-7 (81.76) 
implied that the methyl group at C-7 is equatorial as shown in the proposed structure. 
Further confirmation of the assigned chemical shifts for the structure was 
obtained by running a long range HETCOR experiment. The long range correlation 
as shown in Figure 2.6 helped to establish the chemical 5h1ffs of the quaternary C 
atoms. 
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Table 2.4. 1 Hand 13 CNM R assignments f or compoun d (21) 
Position 13ca lHb lHc 
CDCl3 C6D6 
1 41.3 CH2 2.83, 2.63 2.57, 2.13 
2 197.6 C - -
3 135.7 C - -
4 146.2 CH 6.24 5.82 
5 42.6 CH 4.08 3.56 
6 43.4 CH 2.20 1.52 
7 29.0 CH 2.10 1.76 
8 50.4 CH2. 2.43, 2.15 1.67, 2.24 
9 202.6 C - -
-
10 134.1 C - -
11 143.5 C - -
12 22.9 CH3 2.02 1.99 
13 21.8 CH3 1.91 1.47 
14 19.4 CH3 0.99 0.58 
15 15.2 CH3 1.73 1.65 
a 8, ppm from TMS. Multiplicities determined using DEPT spectrum. Chemical 
shifts have comparable values in CDCb and C6D6. 
b 8 from TMS in CDCl3 , 
C87 .15 in C6D6 at 300 MHz. 1 H NMR J values are given in the Experimental 
section. 
>, 
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A review of the literature showed that the cadinene (21) had been first 
by BohlMo. l'°'/1'\ and Gvpfa. 
isolated from Ageratina adenophora (syn. with E. adenophorum) in 198 ~ 71 Their 
structural assignment was based on I H NMR and spin-decoupling experiments which 
were comparable to the physical data reported here. However, no 13C NMR data has 
been reported for the compound. Several studies have also been carried out on the 
determination of the stereochemistry of cadinenes of related structure which are in 
agreement with (21).72, 75, 76 
2.83 
H 
H 
Figure 2.6. Key LR-HETCOR correlations 
establishing the chemical shifts of the quaternary C atoms in compound (21) 
Biochemical studies 77, 78 on the occurrence of the sesquiterpene (21) in older 
leaves of E. adenophorum suggested that it may be one of the most important 
compounds in terms of chemical defence and takes over the role of the chromenes 
which are the protective chemicals in young seedlings. It has been found to exhibit 
contact toxicity and growth retarding activity against neonate larvae of the variegated 
cutworm Peridroma saucia (Noctuidae).78 
, I 
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D. Experimental 
1. General Procedures 
Solvents and reagents were purified and dried when necessary, according to 
the procedures of Perrin and Annarego.79 Anhydrous solvents were distilled prior to 
use. Light petroleum refers to the fraction of b.p. 60-80°C. 
Flash chromatography was carried out using 230-400 mesh silica gel. 
Preparative-layer chromatography (PLC) was effected on 1 mm Merck silica gel 60 
F254 plates or a Harrison Research chromatotron Model 7924 T with Merck silica gel 
PF2s4+366 as adsorbent and bands detected by exposure to short-wavelength 
ultraviolet light. Analytical thin layer chromatography (TLC) was done on 0.25 mm 
Merck silica gel 60 F254 plates. Reversed phase analytical TLC was carried out 
using precoated 0.25 mm Merck RP-18 F254s plates. Thin layer chromatograms were 
visualized under ultraviolet light and/or by spraying with 13% vanillin in sulfuric 
acid followed by heating at ca. 200°C. 
Gel chromatography was carried out using Sephadex LH-20 in Pharmacia 
· SR columns. Solvent flow was regulated using the peristaltic pump USI Uniscil 
Micro Pump Ump3. High performance liquid chromatography (HPLC) was 
performed using a Maxima 820 chromatography workstation with a Waters 510 
HPLC pump and either a Waters Lambda-Max 481 AZ LC spectrophotometer or a 
Waters differential refractometer R401 as detector. All tech CN-bonded silica column 
(10µ, 10x250 mm) was used for normal phase HPLC runs while Waters Prep Nova-
0 
Pak HR C18 (60A, 6 µm, 7.8x300 mm) column was used for reverse phase HPLC. 
Melting points were determined on a Reichert hot-stage apparatus and are 
uncorrected. Microanalyses were carried out by the Australian National University 
Microanalytical Services Unit. 
t' 
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Ultraviolet spectra were recorded on a SHIMADZU Model UV-160 UV -
Visible spectrophotometer. Infrared spectra were recorded on a Perkin-Elmer 1800 
(FT) spectrophotometer as films or carbon tetrachloride solutions. 
Low resolution electron impact (EI) mass spectra were recorded at 70 e V on 
a VG Micromass 7070F double-focusing mass spectrometer coupled to an Incas data 
system. High resolution EI mass measurements were carried out on the same 
instrument by peak matching, using perfluorokerosene as internal reference. The 
molecular ion (M+) if present, significant high mass ions and the more intense low 
mass are reported. 
Fast atom bombardment (FAB) mass spectra were obtained using a VG 
ZAB-2SEQ spectrometer using glycerol as matrix. High resolution FAB mass 
measurements were obtained using the same instrument with tetrameric 
trifluoroethylphosphonitrilate as internal reference. 
1 H NMR spectra were recorded on the following instruments: Varian 
Gemini-300 at 300 MHz, Varian VXR-300S at 300 MHz and a Varian VXR-500 at 
500 MHz. Tetramethylsilane (TMS) or the solvent signal was used as the internal 
reference and the chemical shifts are quoted in 8 values (ppm downfield from TMS). 
The coupling constants (J values) are reported in Hz. The following abbreviations 
were adopted to indicate the multiplicity or shape of the signal: s (singlet), d 
(doublet), t (triplet), q (quartet), quin (quintet), m (multiplet) and br s (broad singlet). 
Deuterated chloroform (CDCl3) without a TMS internal reference was kept over 
anhydrous potassium carbonate to remove acid and water. 
13C NMR spectra were recorded on the following instruments: Varian 
Gemini-300 at 75.5 MHz and Varian VXR-300S at 75.43 MHz. The solvent signal 
or TMS was used as the internal reference and resonances are quoted in ppm from 
TMS. 
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Two-dimensional (2D) NMR experiments such as COSY, DQF-COSY, 
HETCOR, long range HETCOR, HMQC and HMBC were carried out using Varian 
VXR-300S or Varian VXR-500 instrument. Standard VARIAN pulse sequences were 
used. Experiments were performed on non-spinning samples to reduce t1 noise. 
NMR parameters used in the experiments such as 90°pulse and relaxation time (T 1) 
were determined for each sample. The number of transients and increments per scan 
employed depended on the size and amount of each compound. 
Homonuclear (lH-lH) 2D experiments (DQF-COSY) were run in the phase-
sensitive mode employing the minimum observed spectral region determined from 
the lD spectrum, and using a recycle delay (d1) of 1-3 times the relaxation time (T1). 
The weighting function used was an unshifted sine bell in both dimensions. The 
spectra obtained were not symmetrized. 
Heteronuclear (1H_l3C) correlation experiments in the conventional 13C-
detected mode were run using recycle times of around 1-2 sec. The average Jc, H 
values employed for HETCOR experiments were determined from the 13c;= spectrum 
recorded by the gated decoupling technique. Data processing was carried out using 
an unshifted sine bell weighting function for both dimensions. 
1 H- l 3C correlations for samples in small amounts were determined using 
reverse, 1 H-detected heteronuclear experiments which were run by a staff member of 
the UNMRC (University Nuclear Magnetic Resonance Centre). For one-bond 
correlations (HMQC), the evolution delay used was optimized for the average 
measured Jc, H for each sample, while in the multiple bond experiments (HMBC), 
delays were optimized for Jc, H 8Hz. 
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2. Experimental Details 
Extraction and purification of eupalitin-3-0-galactoside (20). * The 
powdered dried plant material (75g) was macerated with ethanol-water (lL), heated 
to 100°C, then filtered. The filtrate was concentrated to 500 ml, then extracted with 
Et20 (800 ml). The aqueous fraction was extracted with EtOAc (lL) and the organic 
extract evaporated in vacuo. The residue was chromatographed on a Sephadex LH-
20 column and the fractions monitored by TLC (CHCl3/MeOH/ AcOH/H20 , 
60:30:5:5 as developing solvent). The fractions which showed a yellow spot with Rf 
0.60 after spraying with H2S04 were combined and concentrated to give (20) (0.7g, 
O.lOo/o) which was recrystallized from MeOH. Toxicity tests were carried out on the 
crystalline material but the results were variable and inconclusive. Final purification 
was effected by dissolving the sample in the upper layer of 13: 8 :4 
CHCl3/MeOH/H20 mixture and extracting with the lower layer of the solvent 
system. Concentration of the extract under vacuum yielded eupalitin-3-0-
galactoside [3-(galactosyloxy )-5-hydroxy-2-( 4-hydroxyphenyl-6, 7-dimethoxy-4H-1-
benzopyran-4-one] (20) light yellow needles , m.p. 148-151 °C. UV Amax see Table 
2.1. lH NMR, see Table 2.2. 13C NMR, see Table 2.3. Negative FAB-MS mlz 491 
(M-H)-, 329 (M-H-162)-, positive FAB-MS m/z 493 MH+, 331 (MH+-162). EIMS 
m/z 330 (M+-162, 30%), 312 (6), 287 (30), 165 (6), 12 1 (24). Accurate mass 
measurement m/z 330 calc. 330.0721. C17H1407 requires 330.0740. 
Acetate derivative of eupalitin-3-0-galactoside (25). The compound (20) 
( 19 .4mg, 0.04 mmol) was added to a pre-cooled mixture of acetic anhydride (0.20 
ml) and pyridine (0.25 ml) and stirred at room temperature for 48 h. The mixture 
was poured into iced water and then extracted with CHCb. The CHCl3 layer was 
washed with HCl (aq), satd. NaHC03 (aq), dried over MgS04 and evaporated to 
* Isolation was carried out by Dr. Peter B. Oelrichs at the National Centre for Environmental 
Toxicology, Brisbane. 
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dryness. Column chromatography (using 30o/o EtOAc-light petroleum as eluent) 
afforded the acetylated product (25). (22mg, 76% ). 1 H NMR, see Table 2.2. 13C 
NMR (CDCl3, 75.42 MHz) 20.5, 20.5, 20.6, 20.9, 21.0, 21.1 (6 x OCOCH3), 56.4 (7-
0CH3), 60.7 (C-6"), 61.5 (6-0CH3), 66.8 (C-4"), 69.1 (C-2"), 70.6 (C-3", C-5"), 
98.0 (C-8), 99.5 (C-1 "), 111.5 (C-10), 121.2 (C-3', C-5'), 128.1 (C-1 '), 130.3 (C-2', 
C-6'), 136.0 (C-3), 139.5 (C-6), 152.2 (C-9), 153.1 (C-5), 154.9 (C-2), 157.8 (C-7), 
166.4 (C-4'), 168.9, 169.4, 167.0, 170.1, 170.2, 172.0 (6 x OCOCH3). LR-
HETCOR, see Figure 2.5. 
Isolation of the cadinene (21 ). * The powdered freeze-dried leaves ( 1 OOg) 
were extracted with MeOH (1.5L), and the combined extracts evaporated in vacuo. 
The residue was distributed between water (100 ml) and ethyl acetate and the organic 
layer evaporated to dryness. The residue was chromatographed on a silica gel 
column, eluting first with dichloromethane (DCM, 200 ml) and then with 2% EtOAc-
DCM (500 ml). The fractions were followed by TLC and tested for the presence of 
the active principle by monitoring the production of specific damage to the small 
intra-hepatic bile ducts in mice. The toxin was found present in the fractions eluted 
with 2% EtOAc-DCM, and these fractions were combined and evaporated to dryness. 
The colored impurities were removed by passing through a XAD-2 reverse phase 
column using MeOH/H20/CHCl3/ (85: 15:5) as eluent. The eluate was dried under 
reduced pressure (40°C), chromatographed on silica gel column eluting with 2% 
EtOAc/DCM to yield the pure toxin (21) (737mg, 0.7% ), Rf 0.4, 5%Et0Ac/DCM as 
developing solvent. 9-0xo-10,11-dehydroageraphorone {l,3,4,4a,5,8a-hexahydro-
4, 7-dimethyl-1-( 1-methylethylidene )-[4S-( 4a,4aa,8aa)]-2,6-naphthalenedione} (21). 
Colorless oil, [a]D +279 (0.014 g/ml in CHCb), IR Umax (CCl4)/cm-l 2960, 1675, 
1372, EIMS m/z 232 (M, 43.5%), 217 (M-CH3, 7), 189 (M-C3H7, 19), 161 (189-
CO, 76). (Accurate mass measurement gave M+, Cale. 232.1463. C15H2002 requires 
*Isolation and toxicity testing was carried out by Dr. Peter B. Oelrichs at the National Centre for 
Environmental Toxicology, Brisbane. 
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232.1463). lH NMR (C6D6, 300 MHz) 80.58 (3H, d, J 6, H-14); 1.47 (3H, s, H-13); 
1.52 (3H, m, H-6); 1.65 (dd, J 2.7, 1.5, Hwl5); 1.65 (dd, J 12, 14, H-8'); 1.76 (ddU 
2.4, 10, H-7), 1.99 (s, H-12); 2.13 (dd, J 4.5, 15.9, H-1'); 2.24 (dd, J 3.6, 14.1, H-8); 
2.57 (dd, J 2.4, 15.9, H-1); 3.56 (dd, J 4.5, 2.1, H-5); 5.82 (dd, J 1.8, 1.5 Hz, H-4). 
13C NMR data, see Table 2.4. 
CHAPTER III 
NATURAL PRODUCTS FROM 
WEDEL/A ASPERRIMA BENTH. 
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A. Introduction 
1. Mitochondrial ADP/ ATP Transport Inhibition 
a. Atractyloside and its Analogues 
ADP/ ATP transport across the mitochondrial membrane is inhibited by 
certain glycosides containing the norkaurene aglycone, atractyligenin (29). The 
initial source of these specific inhibitors was the Mediterranean thistle Atractylis 
gummifera L. which has been known in North Africa and in some Mediterranean 
countries for its therapeutic and toxic properties. 80 
··, 
'"oH 
Atractyligenin (29) 
The first toxic compound (LDso 143 mg/kg) isolated from the plant in 1867 
was atractyloside (ATR, 30) which was initially named potassium atractylate. 81 
Reinvestigation of the plant in 1906 led to the conclusion that the structure of ATR 
contained D( + )-glucosyl, isovaleryl, carboxyl, sulfate and hydroxyl functionalities. 81 
Interest in the toxic compound of the plant was further revived after an accidental 
poisoning in 1956 of a class of Italian schoolchildren, and led to the chemical and 
biochemical studies on A TR. The structure of ATR (30) was assigned by Piozzi et. 
al. 82, 83 from 1 H NMR and chemical studies. ATR has a D-glucose linked by a ~-
glycosidic bond to the hydroxyl group at C-2 of the norditerpene atractyligenin. The 
sugar moiety has two sulfate groups at C-3' and C-4', and an isovalerate residue at C-
2'. The terpene portion was also confirmed to be a 4-carboxy-2,15-dihydroxy 
norkaurene. 
11 ' 
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A second compound isolated from the plant was carboxyatractyloside 
(CATR, 18). Danielli et. al. 84, 85 determined its structure and named it as such due to 
the presence of a second carboxyl group at C-4 of the aglycone. It was shown to be 
identical to the compound called gummiferine that had been previously isolated from 
the roots of the plant. 86, 87 CATR was found to be more toxic (LDso 2. 9 mg/kg) than 
ATR and was possibly the active substance present in the fresh plant that undergoes 
decarboxy lation to form the A TR found in the dried material. Epi-atracty loside ( epi-
A TR, 31) was also isolated during the production of the 35S-labelled inhibitors from 
extracts of the plant grown on 35S-sulfate. 88 
Atractyloside-type compounds as well as other derivatives have also been 
isolated from other plants. ATR (30) and atractyligenin (29) have been found in 
Callilepsis aureo[a89, a plant that has been used in herbal medicine by Zulus and 
African people, which has been reported to contain a toxic resin. Wedelia glauca , a 
plant known for its lethality to cattle has also been shown to contain the toxic 
compound ATR (30) .90 
Green coffee beans (Coffea arabica L. ) have been reported to contain 
atractyligenin (29), and its glycosides (32), (33)9 1 and (34)92, which were found to be 
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less toxic than ATR. Atractyligenin and its glycoside derivative (32) have also been 
isolated from Drymaria arenarioides, a plant found in the semi desert areas of 
northern Mexico and southern United States, which is said to be responsible for 
deaths of livestock that accidentally feed on it. In addition, the plant has been found 
to contain atractyligenone, the 2-keto derivative of (29), and another atractyligenin 
glycoside (35). 93 
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The presence of carboxyatractyloside in other plants such as Xanthium 
strumarium (syn. Xanthium pungens) has been reported.94 CATR has been isolated 
from the seeds and very young seedlings of the plant which have been known to 
cause illness and deaths of livestock, especially swine.95 Recent studies on the plant 
have shown the presence of compound (36), the didesulfated derivative of CATR, 
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and (37), another didesulfated CATR derivative which has a 3-methylpentanoyl ester 
substituent at C-2' instead of the isovaleryl side chain.96 The same analogue of 
CATR (36) was also isolated as its methy 1 ester derivative from a related plant 
Xanthium spinosum. 97 
Other analogues of ATR and CATR are the kaurene glycosides parquin (38) 
and carboxyparquin (39) which were recently isolated from the dried leaves of the 
shrub Cestrum parqui.98 The plant has been reported to cause sporadic cases of cattle 
poisoning in South America and Australia and has also been documented to cause 
poisoning of sheep, horses, pigs and poultry. The parquins differ from the 
atractylosides in the unusual glycosidic portion which contains a carboxyl group at C-
3' and a y-lactone at C-4' instead of sulfate groups. Carboxyparquin, which has an 
additional carboxyl group at C-4 as in carboxyatractyloside, has been found to be 
toxic, while its co-metabolite (38) is relatively non-toxic. 
HO 
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Another compound related to the atracty lo sides is wedeloside (WED, 17), 
which was isolated from the herb Wedelia asperrima Benth. (Compositae).99 The 
plant, which is also known as yellow daisy, is distributed mainly in Queensland, 
Northern Territory and Western Australia . Poisoning by the plant has been 
documented in northwestern Queensland where starving sheep which have been 
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transported in railway trucks for one to two days are unloaded at railway sidings into 
paddocks which contain W. asperrima. 36 
WED (17), the major toxic component of the plant, is structurally similar to 
CATR (18), differing in the aglycone only by the presence of an additional hydroxyl 
substituent at C-13.33 The 3-methyl-1-oxo-butyl substituent is also present as a 
glycosidic functionality but as an amide of 2'-deoxy-2'-aminoglucose instead of a 
glucosyl ester as in CATR.32 The two sulfate groups at C-3' and C-4' in CATR are 
also lacking in wedeloside. Instead, there is a 3-phenylpropionyl substituent at C-3', 
and C-4' remains unsubstituted. 
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Subsequent studieslOO on the plant reported the presence of two additional 
toxic components ( 40) and ( 41) which are both derivatives of WED. Both ( 40) and 
(41) possess an L-rhamnosyl moiety at C-4' of the aminoglycoside ring, while (41) 
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has an additional hydroxyl group at the benzylic position of the 3-phenylpropionyl 
substituent. 
A related plant Melanthera biflora (syn. Wedelia biflora) has been reported 
to contain the toxic compound bifloratoxin (42).lOl It has an aglycone identical to 
that of carboxyatractyloside, but has .the glycosidic portion similar to that of the 
wedeloside analogue (41) with an additional acetate group at C-6'. 
b. Structure-Activity Studies of Atractyloside and Analogues 
Biochemical studies 102 on ATR showed that it prevents the access of 
external ADP to its phosphorylation site in the inner mitochondrial membrane and 
therefore acts as inhibitor of a mitochondrial transport protein specific for ADP. 
Studies on structure-activity relationship using different atractyloside derivatives 
revealed that there are several structural features which are crucial for the inhibitory 
activity of the compound. The axial carboxyl group at C-4 is an .important 
functionality since reduction to a hydroxyl or a methyl group, and derivatization to an 
ester led to loss of inhibitory activity. The exocyclic methylene group at C-16 is also 
important because hydrogenation caused a two- to three-fold decrease of the activity. 
Another essential functionality is the C-15 hydroxyl group since acetylation decreases 
the inhibitory effect of the compound as compared to ATR. The compound still 
remained as a competitive inhibitor of ADP/ ATP transport when the isovalerate or 
sulfate groups were removed, but became less efficient than ATR. Modification of 
the C-6' hydroxyl group by succinylation or acetylation 103 did not result in significant 
loss of the biological properties. 
These results implied that for ADP/ ATP inhibition, the presence of the 
hydrophobic and hydrophilic groups is important for the affinity of ATR to its 
receptor site(s). The hydrophobic portion enables the molecule to penetrate 
membrane lipids while the polar part protrudes from the phospholipid bilayer and 
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stays near the surface of the membrane where it can react with the polar part of the 
ADP carrier.102 
The presence of a second carboxyl group at C-4 as in CATR makes the 
compound a more powerful inhibitor of ADP/ ATP transport and is non-competitive 
with ADP.104 The isomer of ATR, epi-atractyloside (31), which has the carboxyl 
group in the equatorial position is also a very effective inhibitor of ADP/ ATP 
translocation and non-competitive with ADP.105 From these observations, it was 
suggested that it is not the additional carboxy 1 group in CA TR that is required for the 
high affinity but rather that it occupies the equatorial position. The greater proximity 
of the equatorial carboxyl group to the sulfate groups in both epi-ATR and CATR 
favors the binding to the membrane protein, as in ADP where the three anionic 
charges are also in close proximity. 
Biochemical studies on the other derivatives such as the "coffee glycosides" 
(32) and (33) revealed that they were considerably less toxic and act less strongly as 
inhibitors of the ADP/ATP exchange.34 Wedeloside (17), which lacks the two sulfate 
groups at C-3' and C-4' was also tested · in competitive binding studies. Results 
showed that WED has a high binding affinity for the ADP/ ATP carrier comparable to 
that of CA TR. 34 However, the stoichiometry of binding is such that almost two 
molecules of WED are required to occupy a site compared with one molecule of 
CA TR. The similar affinities of the carrier protein for CA TR and WED were 
surprising at first, since the sulfate groups had been believed to be essential in high 
affinity ligands, and that the presence of at least three negative charges was required 
for effective binding. Tighter binding must then be due to the hydrophobic 
interaction of the phenylpropionyl substituent with the reactive site(s). 
The affinity of the carrier protein for 4'-0-rhamnosylwedeloside ( 40) is 
lower than that of WED and twice the amount of the compound is required to titrate a 
binding site compared with CATR. Thus, the removal of the two sulfate groups in 
CA TR can affect the affinity and changes the stoichiometry of the binding. The 
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stoichiometry could be explained by postulating that two molecules of wedeloside or 
its analogue ( 40), each containing two negatively charged acid groups, are needed to 
replace the four negative groups in carboxyatractyloside, three of which are essential 
for effective binding. 
A separate competition experiment97 carried out between A TR and 
bifloratoxin ( 42) showed that the latter compound also affects mitochondrial 
ADP/ ATP translocation and its binding affinity is considerably higher than ATR. 
c. ADP/ATP Transport Model 
The specific inhibitory effect of CATR on ADP/ ATP transport by binding to 
the carrier protein has led to the understanding of translocational events of the carrier 
on a molecular level using competitive binding studies between various ligands.106 
These in tum gave insights into the physiological and structural features of the 
ADP/ ATP carrier in the mitochondria. 
-
Bongkrekic acid (BA, 43) 
A recent reviewl07 discussed the carrier protein that mediates ADP/ ATP 
exchange across the mitochondrial membrane based mainly on biochemical studies 
using CATR and another inhibitor bongkrekic acid (BA, 43). CATR reacts with the 
carrier on the outer face of the inner mitochondrial membrane while BA binds to the 
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carrier protein from the inside. The two conformations of the protein which interact 
with these two inhibitors are named the CATR and BA conformers. 
ADP/ ATP transport proceeds by a sequential mechanism in which both the 
external and the internal substrates bind to the carrier before the exchange occurs. In 
the proposed molecular model, the functional ADP/ ATP carrier protein is a tetramer. 
One of the dimers of this tetrameric carrier binds to an externally added nucleotide, 
while the other dimer binds with an internal nucleotide. After binding and formation 
of a ternary complex with any of the two conformers, interconversion of the 
conformer complexes can occur and the transport of ADP/ ATP is facilitated. The 
action of CATR and BA involves the splitting of the functional tetramer into inactive 
dimers which inhibits the translocation of ADP/ATP. 
2. Relevance of the Present Study 
The specific inhibitors of ADP/ ATP translocation across the mitochondrial 
membrane have · been very important in elucidating the dynamics of the process. 
They have also been of great help in studying the structure and conformation of the 
carrier protein involved in the translocation. However, the specific effects of 
different functionalities of the inhibitors on the affinity of the carrier protein need to 
be further defined. The relationship between the structure of the inhibitor and the 
type of inhibition as well as the stereochemistry of binding still has to be explored. 
The present work continues the ongoing search for toxic and non-toxic 
compounds related to wedeloside. It is proposed to use them to study structure-
activity relationships relating to ADP/ ATP transport inhibition. It has been 
mentioned that compounds which have gem-dicarboxyl groups like CATR and WED 
easily undergo decarboxylation. The !ability of the functional groups in CATR and 
WED makes it difficult for partial or total synthesis of analogues of these compounds 
to be carried out, although attempts to synthesize the wedeloside aglycone, 
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wedeligenin, are continuing in our research group.108 The isolation of wedeloside 
analogues from plants such as Wedelia asperrima Benth. is another means of 
producing compounds that can be used for competitive binding studies. 
The wedelosides (17), (40) and (41) had been previously isolated from W. 
asperrima using toxicity testing to follow the isolation and purification procedure. It 
was the aim of the present study to carry out a non-specific, broadly based search for 
any wedeloside analogues that may have been overlooked in the earlier studies 
because of their low levels or low toxicity. In carrying this out, a number of 
unrelated compounds, some of which have not been previously reported, were 
isolated as discussed in the following sections. 
B. Isolation of the Natural Products 
Previous isolation procedures32, 96, 98 of wedelosides were monitored by 
toxicity testing. The extraction was often carried out at elevated temperatures 
followed by stages in the purification process where the extracts were treated with 
acids and bases. In the present non-specific isolation of wedeloside analogues, a 
consideration of the lability of the functional groups present prompted the 
modification of previous isolation procedures. The extraction was carried out at or 
below room temperature and chromatography techniques which did not necessitate 
the use of acids and bases were selected for the purification process. Silica gel 
chromatography, which has been shown 1 o 1 to result in a high degree of 
decomposition during the isolation of bifloratoxin, was also avoided in the present 
search for wedeloside analogues. Since the target compounds were expected to be 
very polar, the common method of evaporation of the polar solvents (e.g. water, 
butanol) in vacuo by heating on the water bath was avoided by using a dry ice-
acetone condenser. This facilitated the removal of the solvent while maintaining the 
water bath at ambient temperature. 
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The stems and leaves of W. asperrima were collected, dried and milled by 
Dr. P. B. Oelrichs in Queensland and sent to Canberra. The plant material was 
extracted (Figure 3.1) first with ethyl acetate using a mechanical shaker at room 
temperature to remove most of the chlorophylls and other non-polar substances. The 
residue was then extracted with MeOH/H20 ( 1: 1), and the aqueous extract 
subsequently extracted with dichloromethane and n-BuOH. 
The initial ethyl acetate extract was concentrated and the residue purified by 
repeated column chromatography on silica gel using hexane with increasing amounts 
of ethyl acetate as eluting solvent. This resulted in the isolation of ~-amyrin ( 44) and 
its acetate (45) and keto (46) derivatives from the less polar fractions (Fl) (see 
Section C.1). The fraction (F2) eluted with increasing ethyl acetate concentrations 
appeared to be mixtures of phytosterols based on their initial NMR and mass spectra 
and was not further investigated. 
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~-amyrone ( 46) 
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Scheme 3.1. Initial extraction procedure for Wedelia asperrima 
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Scheme 3.2. Purification of the aqueous fraction 
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Scheme 3.3. Purification of dichloromethane fraction 
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The plant residue after initial ethyl acetate extraction was steeped in 1: 1 
MeOH/H20 and kept at 5°C for two months. The mixture was then filtered and the 
filtrate concentrated under vacuum. Upon evaporation of the solvent, most of the 
green chlorophyll-containing matter adhered to the sides of the flask and the aqueous 
residue was left as a brownish solution at the bottom. 
The concentrated aqueous fraction was partitioned between water and 
dichloromethane (Scheme 3.2). The_ organic extract was then added to the green 
mixture collected initially from the aqueous methanol extract (Scheme 3.3). The 
organic mixture was concentrated under vacuum, dissolved in methanol and extracted 
with hexane. The hexane-soluble fraction consisted mainly of chlorophylls and was 
discarded. 
While the above purification procedures were being carried out, the plant 
residue (F5) (Scheme 3.3) was exhaustively extracted by soaking again in 
MeOH/H20 (1:1) and kept at 5°C for two weeks. The subsequent steps in the 
purification process were similar to those used for the first aqueous methanol extract. 
The more polar components of the dichloromethane fraction from the first 
and second aqueous methanol extractions (Scheme 3.3) were dissolved in methanol. 
The methanol solution was concentrated, and the residue passed through a PVP 
(polyvinylpolypyrrolidone) column using EtOAc/MeOH (80:20) as eluting solvent. 
The first few fractions obtained were still non-polar chlorophyll-containing and were 
discarded. The remaining fractions were monitored by both normal and reverse phase 
TLC and were finally purified using RP-HPLC to yield the flavanones (47) and (48), 
and a mixture of the chalcones (49) and (50), of which (47) and (50) had not been 
previously reported. 
After the dichloromethane extraction, each aqueous fraction was extracted 
with n-BuOH to separate the organic polar compounds from the inorganic salts (left 
mainly in the aqueous phase). The water-saturated n-BuOH extract was concentrated 
under vacuum, and the residue dissolved in methanol. Solids precipitated out of the 
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mixture which when filtered and checked by TLC and melting point determination 
appeared to be mainly inorganic salts. 
OH 
R 
HO 0 
0 
R = OCH3 (47) 
R = H (48) 
Purification of the methanol soluble fractions from the two n-BuOH extracts 
was carried out using different procedures. The first methanol-soluble n-BuOH 
extract (Scheme 3.2) was purified by passing through Sephadex LH-20 using MeOH 
as eluent. An attempt to purify the second extract was carried out using DCCC 
(droplet counter current chromatography). 
OCH3 
OH 
R1 
OH 0 
HO 
~-D-glu(p) = HO 
OH 
R1 R2 
(49) H H 
(50) OCH3 H 
(51) H ~D-glu(p) 
(52) OCH3 ~D-glu(p) 
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The mixture that was passed through Sephadex LH-20 yielded partially 
purified fractions. The first fraction proved to be a mixture of wedelosides while the 
last few fractions were mixtures of chalcone and chalcone glycosides. Further 
purification of these fractions was facilitated using repeated RP-HPLC and yielded 
the chalcone (50), and the chalcone glycosides (51) and (52). RP-HPLC of the 
wedeloside mixture using RP-18 column and a gradient running from 30 to 10 o/o 
H20/MeOH over 15 min resulted in the wedeloside sulfate (53) eluting after 6.5 min 
and the mixture of the rhamnosyl wedelosides (40) and (41) after 5.6 min. 
OH 
0 
R1 
H 
OH 
H 
0 
H3C 
L-rha = HO 
R2 
L-rha (40) 
L-rha (41) 
OS03H (53) 
. 
. , 
~ 
OH 
HO 
The methanol soluble fraction of the second n-BuOH extract which was 
subjected to DCCC separation using a two-phase system composed of 
CHCl3/MeOH/n-PrOH/H20 (5:6: 1 :4) still resulted in mixtures. These were passed 
through Sephadex LH-20 which resulted in partially purified compounds. The 
mixtures were checked for the presence of wedelosides by comparing their RP-
HPLC, TLC chromatograms and 1 H NMR spectra with those of standards. However, 
the results indicated that wedeloside and its analogues appeared to be absent in the 
mixtures . It appears that most of the wedelosides were extracted in the first batch. 
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The solvent system used in the DCCC might not have been the best one which 
resulted in the poor separation, although different solvent systems were tried 
following the proceduresI09 for solvent selection. 
C. Structure elucidation 
1. Amyrins 
19 21 
12 22 
28 
16 
10 
H 8 15 27 7 
R 
24 23 
R 
P-amyrin (44) 
P-amyrin acetate ( 45) 
P-amyrone ( 46) 0 
Repeated column chromatography of the initial ethyl acetate extract yielded 
the triterpenes P-amyrin (44) and its acetate (45) and keto (46) derivatives from the 
hexane soluble-fraction. Their structures were confirmed by comparison of 
spectroscopic and physical data with literature values.11 O, 111 The 1 H NMR data was 
not particularly helpful in the determination of the structure because of overlapping 
signals in the hydrocarbon region of the spectrum, but the MS and l 3C NMR data 
proved to be of immense value in the structure assignment of the triterpenes. 
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The mass spectra of the three compounds all showed a common fragment ion 
of m/z 218 which implied the presence of a common structural/skeletal type. 
Accurate mass measurement of the m/z 218 ion found that it corresponds to C16H26· 
This is a characteristic Retro-Diels Alder fragment ion formed by a triterpene of an 
oleanane or ursene skeleton with a C12-C13 double bond (Figure 3.1). 11 2, 113 This led 
to the conclusion that they had the same C-D-E ring systems and differed only in the 
substitution in ring A or B. 
A 
R 
E 
m/z 218 
• + 
-H 
A 
R 
Figure 3 .1. Characteristic mass spectral fragmentation of 
an olean-12-ene 
+ 
• 
B 
Comparison of the 13C NMR data of compound ( 44) with the published data 
for common triterpenes indicated that it was ~-amyrin.110 Compound ( 45), which has 
an additional acetate group and differed only in the chemical shift of C-3 and the 
neighboring atoms C-2 and C-4, was confirmed to be the 3-acetate of ~-amyrin by 
comparison with the reported values.110 Compound (46) which has one degree of 
unsaturation more than (44) as deduced from HR-EIMS, had a carbon signal at 218 
ppm characteristic of a carbonyl functionality. This was assigned as the 3-keto 
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derivative of P-amyrin and was confirmed by comparison of the I 3c NMR and 
melting point with the literature values. I IO 
2. Chalcones and Flavanones 
OCH3 
OH 
R 
I s· 
6 I 2 6' 3 
5 
0 
R = OCH3 (47) 
R=H (48) 
The chalcones and their corresponding flavanone isomers and glycoside 
derivatives were isolated from the n-BuOH extract and the polar fraction of the 
dichloromethane_ extract. Assignment of their structures was based mainly on the 
MS, UV, and ID NMR data (Section B.1). As the samples were only present in very 
small amounts, heteronuclear 2D NMR experiments were not carried out. Since 
chalcone-flavanone isomerization occurs in biological systems (refer to Scheme 2.3), 
it could be assumed that the substitution patterns of the aromatic rings in the 
flavanones were similar to those in the chalcones. The confirmation of the structures 
of one previously unreported flavanone-chalcone isomer pair ( 47) and (50) was 
carried out by chemical synthesis (Section B.2). 
a. Natural Products 
The first flavanone isolated was assigned the structure ( 47). The EI mass 
spectrum showed the molecular ion at m/z 316 which by accurate mass measurement 
corresponded to a molecular composition of C17H1606. The mass spectrum also 
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showed significant ions at m/z 167 (CgH704) and 150 (C10H1002) which could be 
assigned to the characteristic A and B fragments formed upon ionization of a 
flavanone (Figure 3.2).61 This showed that each aromatic ring had one methoxy and 
one hydroxy substituent. 
OH lt 
7~ 
B J_OCH3 
0 :::::,..... I -
• 
0 
(47) R=OCH3 
(48) R=H 
m/z 167 
m/z 137 
0 
C~+ 
OH 
mlz 150 
m/z 150 
Figure 3.2. Characteristic mass spectral fragmentation of a flavanone upon ionization 
The 1 H NMR spectrum of the compound showed the two methoxy signals at 
b 3.91 and 3.97. · There was also a doublet of doublet at b5.53 for the oxymethine 
proton H-2 as a result of its coupling with the methylene protons at C-3. Naturally 
occurring flavanones exist in the S-configuration and this was verified from the 
coupling of H-2 to the equatorial (b2.84 J 3Hz) and axial H-3 (b3.19 J 13 Hz) which 
were in tum coupled to each other (J gem 17 Hz) resulting in the observed overlapping 
quartets. 
The aromatic protons at b6.64 and 7.61 were consistent with the presence of 
a 1, 2, 3, 4-substitution in the A-ring, based on their ortho coupling constants (J 9 
Hz). This implied that the methoxy and hydroxy groups occupied either the 5, 6; 7, 8 
or 5, 8 positions. The proposed structure ( 47) has the substituents at C-7 and C-8. 
This was deduced from the UV spectrum of the compound in methanol after addition 
of NaOMe or NaOAc. The absence of a 5-0H group which would be hydrogen-
bonded to the car bony 1 group at C-4 led to the isomerization of the flavanone to 
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chalcone in basic medium and resulted in an entirely different spectrum typical of a 
chalcone (Amax 340-390, 220-270)59 as shown in the following transformation. The 
proton signal at 87.61 which was furthest downfield could be assigned to H-5 due to 
the deshielding effect of the C-4 carbonyl group. 
-OH 0 
0 0 
Figure 3.3. Conversion of the flavanone to the ionized chalcone in the presence of a 
base (NaOMe or NaOAc) 
In ring B, the H-2' signal appeared as a doublet at 87.23 meta-coupled (J 2 
Hz) to H-6' (87 .06), which was in tum ortlio-coupled (J 8.2 Hz) to H-5' (86.92). The 
relative resonances of H-2' and H-6' could be used to distinguish the position of the 
methoxy substituent.59 H-2' is shifted downfield compared to H-6' which implied the 
substitution of the methoxy group at C-3', and consequently the presence of the 4'-
0H. 
The proposed structure then had 3'-0Me, 4'-0H substituents in ring B and a 
7, 8- disubstitution in ring A. The positions of the methoxy groups were inferred 
from their carbon resonances (Table 3.1). The methoxy signal at 56.5 ppm was 
assigned to 3'-0Me which was characteristic of a methoxy substituent with at least 
one free ortho- position.114 The methoxy signal further downfield at 61.2 ppm was 
assigned to 8-0Me which has no free ortho- position. The 7t electrons of the oxygen 
of a diortho-substituted methoxy group are not fully conjugated with the aromatic 
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ring and due to this non-coplanarity is relatively deshielded resulting in the downfield 
shift of the C resonance. 
These results led to the assignment of structure ( 47) for the compound. The 
other 13C assignments were mainly based on comparison with published data62 on 
related compounds. A search of the literature showed that this compound had not 
been previously described. 
The other flavanone isolated w-as compound ( 48). The 1 H NMR spectrum of 
this compound showed the characteristic signals and coupling constants for the 
protons in ring Cat 82.79, 3.18 and 5.47. There were also two sets of aromatic 
protons both of which had the same 1, 2, 4- substitution pattern. In contrast to (47), 
the compound ( 48) had only one methoxy signal. 
The molecular weight of the flavanone ( 48) (M+ at m/z 286 from EIMS) was 
30 mass units less than that of (47). Its composition C16H1405 implied that (48) 
lacked one of the methoxy substituents present in ( 47). The mass spectrum of the 
compound showed significant m/z 137 (C7H503) and 150 (C9H1002) ions which 
could be assigned to the corresponding ring A and B fragments formed upon 
_ionization of the flavanone (Figure 3.2). This indicated that ring B contained the 
methoxy and hydroxy substituent while ring A had only one hydroxy functionality. 
The positions of the B ring substituents in (48) were assigned as C-3' and C-
4', similar to that in ( 47), by comparison of their 1 H and 13C NMR spectra. The 
hydroxy substituent in ring A was located at C-7 by comparison of its UV, lH and 
13C NMR spectra with that of ( 47). It could then be deduced that compound ( 48) had 
a similar structure to (47) except for the absence of a methoxy group at C-8. 
The first chalcone fraction isolated from the dichloromethane extract was 
still a mixture of two compounds ( 49) and (50) as inferred from its 13C NMR 
spectrum, which were not readily separated. It was decided to determine first the 
structure of the chalcone (50) which was isolated separately from the n-BuOH 
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fraction and the subsequent characterization of the other compound ( 49) was carried 
out by subtraction of the carbon resonances of (50) from that of the mixture. 
The 1 H NMR spectrum of (50) exhibited signals mainly in the aromatic 
region except for the methoxy signals at 83.38 and 3.94. There were two sets of 
aromatic protons that showed a 1, 2, 4 substitution pattern in one ring and 1, 2, 3, 4-
substitution in the other aromatic ring, as deduced from their coupling constants. 
There were also two olefinic protons trans to each other at 87.64 and 7.80 (J 15 Hz) 
0~ a dovble bol'\d 
A. in conjugation with the aromatic system. These led to the deduction that 
.... 
the compound had a chalcone skeleton. The doublet at 87 .64 was characteristic of the 
H-a resonance while the signal at 87.80 corresponded to H-~. 
5' 
~ 
1' a 
OH 0 
(49) 
(50) 
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(52) 
H 
OCH3 
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The compound showed a molecular ion at m/z 316 which mass measured for 
C17H1606, similar to that of (47). The mass spectrum of (50) also showed significant 
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ions at m/z 167 (CsH704) and 150 (C9H1002). These could be explained by the fact 
that the chalcone readily isomerized to the flavanone either prior to or after ionization 
and therefore gave fragments characteristic of the flavanone. 61 It could then be 
inferred that (50) was the chalcone isomer of (47), which was supported by the 
following spectral data. 
In ring A, the proton signal further downfield at 87 .83 was assigned to H-6' 
which was deshielded by the ortho-carbonyl group. H-6' was coupled to H-5' (86.47 
J 9 Hz) which resonated upfield because of the neighboring oxy-substituents. The 
position of the methoxy group in ring A was again assigned to C-3', which being 
ortho- to two hydroxyl groups caused the methoxy signal to resonate further 
downfield at 61 ppm (Table 3 .1). 
The B-ring substituents were again assigned to C-3 and C-4 based on the 1 H 
NMR spectrum. The presence of the methoxy group at C-3 caused the H-2 signal to 
be shifted downfield at 87.37 compared to the H-6 signal at 87.27 and H-5 at 86.84. 
The corresponding presence of the free 4-0H group was also inferred from the UV 
spectrum of the compound in MeOH after the addition of NaOMe. Addition of the 
strong base caused the ionization of the free 4-0H and resulted in a bathochromic 
shift of 57 nm in the UV spectrum. These results led to the assignment of compound 
(50) as the chalcone isomer of ( 47), which was subsequently confirmed by synthesis. 
A comparison of the lH NMR, 13C NMR and MS data of compound (50) 
with the chalcone mixture of ( 49) and (50) isolated from the dichloromethane fraction 
showed that the second compound ( 49) had one less methoxy group than (50). The 
substitution patterns in the aromatic rings of compound ( 49) were similar to those of 
compound ( 48) as determined by the 1 H-1 H coupling constants. This led to the 
conclusion that the other chalcone component ( 49) was the isomer of the flavanone 
(48). 
It was not surpns1ng that chalcones were isolated together with their 
isomeric flavanones since they can undergo reversible isomerization. Whether the 
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isomers were present initially in the plant material or were formed during the 
different stages in the purification procedure cannot be ascertained. 
The two chalcone glycosides from the n-BuOH fraction were assigned 
structures (51) and (52) by comparison of their MS, 1 H and 13C NMR (Table 3.1) 
data with the chalcones ( 49) and (50). Because of the sub-milligram quantities of 
these compounds isolated, only limited spectroscopic data could be obtained. 
Negative FAB-MS of compound (51) showed a prominent ion at m/z 447 
(M-H)- while positive FAB-MS showed the MH+ ion at mlz 447 which analyzed for 
C22H2501 O· EIMS showed the highest fragment ion at mlz 286 for the aglycone 
indicating the loss of 162 mu and confirming the presence of a hexose unit. 
Comparison of the lH NMR spectrum of (51) with that of (49) showed that the 
aromatic rings in both compounds had the same substitution pattern. Ring B had 3, 
4-dioxy substituents, while ring A had the oxysubstituents at C-2' and C-4'. 
The identity of the glycoside was determined by comparison with reported 
13C NMR data of different hexoses.115 The carbon resonance at 101.4 ppm was in 
agreement with the chemical shift for the anomeric carbon of an 0-linked P-D-
hexopyranoside. The other signals between 62 and 79 ppm closely matched the 
chemical shifts for C-2 to C-6 of a glucopyranoside rather than any hexopyranoside. 
The site of glucosylation was inferred mainly from the 13C NMR spectrum 
of the compound. From literature reports on glycosylated flavonoids, glycosylation 
of a phenolic group causes an upfield shift of the ipso and downfield shifts of the 
ortho and para carbons.115 Comparison of the 13C NMR spectra of ( 49) and (51) 
(Table 3.1) showed marked differences of the carbon resonances in ring A but not in 
ring B. There was an upfield shift of C-4' (-2.3 ppm) and accompanying downfield 
shifts of C-3' ( + 1.3 ppm) and C-1' ( +2.0 ppm). This led to the conclusion that the 
compound had the 3-methoxy-4-hydroxy substituents in ring B and a 4'-glucosyl-2'-
hydroxy substituents in ring A. Thus, compound (51) was the 4'-0-P-D-
glucopyranoside of ( 49). 
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T bl 3 1 13C NMR d f h h I d h . 4' 0 I 'd a a e ata o t e c a cones an t eir - -I o- UCOSl es. .. l 
C (49) (51) (50) (52) 
1 128.4 128.2 127.9 127.6 
2 112.1 112.3 112.2 112.4 
3 151.0 149.6 151.1 151.7 
4 149.4 148.0 149.5 149.7 
-5 116.5 116.7 116.9 117.8 
6 125.1 125.3 125.1 125.5 
1' 114.7 116.7 114.7 116.7 
2' 166.6 166.9 159.4 157.5 
3' 103.8 105.1 136.2 138.3 
41 167.4 165.1 158.6 151.7 
5' 109.2 109.3 109.0 107.9 
6' 133.5 133.1 131.9 136.3 
a 118.6 118.3 118.5 118.5 
'--., 
~ 146.0 147.6 145.8 147.2 
~' 193.5 194.0 194.0 194.6 
3-0Me 56.5 56.5 56.5 56.6 
3'-0Me - - 60.8 61.4 
1" - 101.4 - 101.8 
2" - 74.8 - 74.8 
3" - 78.3 - 78.5 
4" - 71.2 - 71.2 
5" 
- 77 .9 - 78.0 
6" 
- 62.4 - 62.5 
a3, ppm from TMS in CD30D at 75.5 MHz. 
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In its negative FAB mass spectrum, compound (52) showed an (M-H)- ion at 
m/z 477, while in the positive FAB-MS there was prominent ion at m/z 479 which 
mass measured for C23H27011 · This corresponded to compound (50) with an 
additional 162 mu for the hexose unit. Comparison of its spectral data with (50) 
showed similar aromatic substitution patterns in both rings A and B. The glycoside 
portion was also inferred to be a ~-0-D-glucopyranoside based on its Be NMR data. 
The 13C NMR spectrum of compound (52) again showed an upfield shift of C-4' (-6.9 
ppm) and accompanying downfield shifts of C-3' ( +2.1 ppm) and C-1' ( +2.0 ppm), as 
compared to the carbon resonances of (50). These led to the assignment of the 
structure (52) which is a 4'-0-~-D-glucopyranoside of chalcone (50). 
A search of the literature showed that the chalcone-flavanone pair ( 48) and 
( 49) had been previously described in a study on the synthesis of polyhydroxy 
flavonoids.116 Their reported 1 H NMR data were comparable to those obtained in 
this study. The other chalcone-flavanone pair (47) and (50), as well as the chalcone 
glycosides (51) and (52) have not been previously reported. Microbiological assays 
on all of the flavanones and chalcones were carried out as described in Section D. 
b. Synthesis of the Chalcone-Flavanone Isomers (47) and (50) 
Further confirmation of the assigned structures of the isolated chalcones and 
flavanones was carried out by the unambiguous synthesis of the chalcone-flavanone 
pair (47) and (50). Retrosynthetic analysis (Scheme 3.4) revealed that pyrogallol (54) 
and o-vanillin (55) could be used as starting materials for the preparation of the A and 
B ring precursors of the required chalcone intermediate. 
HO 
HO 
HO 
(54) 
OCH3 
OH 
0 
0 
(47) 
<--
OCH3 
OH 
HO 
OH 
OH 0 
(50) 
0 0 
Scheme 3.4. Retrosynthesis of compounds ( 47) and (50) 
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OH 
OCH3 
OH 
(55) 
The synthetic route followed is shown in Scheme 3.5. Gallacetophenone 
. . 
(56) was formed by acylation of pyrogallol (54) using acetic anhydride in the 
· presence of Amberlite IR-20 catalyst. Following the literature procedure! 17 resulted 
in 40-50o/o yield, but extension of reaction time and final purification using a PVP 
column 11 8 gave 83% recovery of the desired product. Selective protection of the 4-
0H group to give (57) was afforded by a benzylation reaction using benzyl bromide 
in DMF and Li2C03 at 60°C under N2. Other reported procedures I 19, 120 for the 
formation of the compound (57) resulted only in the 3,4-0-dibenzylated product. 
Methylation of the 3-0H group to form the protected A ring precursor (58) was 
carried out by adapting a modified procedurel20 using dimethyl sulfate in 
acetone/K2C03 at low temperature. 
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BzO 
HO 
HO 
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HO 
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... 
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OH 0 90% 
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Scheme 3.5 . Synthesis of the chalcone-flavanone pair ( 47) and (50) 
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Condensation of the A ring precursor (58) with the benzylated vanillin (59) 
in 40% aq. NaOH resulted in the dibenzylated chalcone (60). Isomerization of the 
chalcone (60) to the flavanone (61) was carried out by refluxing in ethanol with a 
catalytic amount of phosphoric acid.121 Attempts to cyclize the chalcone using other 
reported reagents such as ethylenediamine in ethanol122 resulted in a mixture of the 
starting materials (58) and (59). 
Removal of the benzyl protecting groups in (60) and (61) turned out to be 
more difficult than anticipated because of the presence of the methoxy and keto 
groups in both compounds as well as the a, ~-unsaturated ketone functionality in 
(60). Hydrogenation of the flavanone (61) in the presence of palladized carbon 
resulted in debenzylation but was accompanied by reduction of the keto functionality 
to a methylene group. Treatment of (61) with aluminium chloride and N,N-
dimethylaniline (DMA) as reported in a recent chalcone synthesis123 did not result in 
debenzylation. 
The use of trimethylsilyl iodide (TMSiI)124 to carry out the debenzylation 
without affecting the methoxy groups was attempted. TMSiI was prepared 125 in situ 
from hexamethyldisilane (HMDS) and I2, to which was added the protected 
flavanone (61) in carbon tetrachloride under N2. The reaction resulted only in the 
monodebenzylated product as determined by 1 H NMR when the temperature was 
kept at 15°C for 3 hours. Increasing the temperature to 30-35°C and the reaction time 
to 24 hours led to the formation of the didebenzylated product but still at a low yield 
(38'% ). This was accompanied by the formation of the monobenzylated product 
(lOo/o) and more polar material which was assumed to be demethylated products 
when excess of the TMSiI was used. Longer reaction time would only have resulted 
in unwanted demethylation. 
The debenzylated product after purification comprised of a 4:3 mixture of 
the flavanone and its chalcone isomer as deduced from the lH and 13C NMR spectra. 
The isomerization of the flavanone to the chalcone could have occurred due to the 
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presence of trace amount of hydrogen iodide. Moisture might have entered the 
reaction flask especially when aliquot samples were taken out when monitoring the 
reaction. 
The spectral data (1 H NMR, 13C NMR, MS) of the synthetic chalcone and 
flavanone isomer corresponded to those obtained for the natural products ( 47) and 
(50) which further confirmed their assigned structures. 
3. W edeloside Analogues 
6" 
H3C 
L-rha = HO 
18' 
HO 
RI R2 
H OH WED (17) 
H L-rha (40) 
OH L-rha (41) 
H S0 3H (53) 
The most polar compounds isolated from the n-BuOH fraction were the 
analogues of wedeloside ( 40), ( 41) and (53). One fraction which eluted as a single 
peak from RP-HPLC was still a mixture based on their FAB-MS data. Negative 
FAB-MS showed two prominent ions at mlz 902 and 918 which were assigned as (M-
H)·, while another set of ions at m/z 858 and 874 corresponded to (M-H-C02) · . 
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Comparison of the 1 H, 13C NMR (Table 3.2) and mass spectral data with published 
resultslOO confirmed the identity of the compounds as the 4'-0-rhamnosyl 
wedelosides ( 40) and ( 41). 
The other wedeloside analogue purified by repeated RP-HPLC was assigned 
the structure (53). FAB-MS on (53) in the negative ion mode using a glycerol matrix, 
revealed the highest ion of significant abundance to be m/z 836 which was assigned 
as (M-H)- (Figure 3.4). This corresponds to wedeloside with an additional 80 mass 
units. Acid hydrolysis of (53) in aqueous methanol followed by trimethylsilylation 
and subsequent GC-MS of the product mixture showed the presence of TMSi-3-
phenylpropanoate (62) and the tri-TMSi derivative of 2-deoxy-2-(3-methyl-1-
oxobutyl) amino-a-D-glucopyranoside (63) (Figu~e 3.5).32 
0 
W mlz 222 
(62) 
Me3SiO 
Me3Sio---..... 
W m/z 536 
(63) 
OSiMe3 
Figure 3.5. Trimethylsilyl derivatives of the acid hydrolysis products of (53). 
The EIMS of (64) (Figure 3.6), the trimethylsilyl derivative of (53 ) , 
exhibited the A+ ion for the aglycone at mlz 65 l which by comparison with published 
data33 corresponded to the aglycone of wedeloside. However, the expected glycoside 
ion G+ of the compound was not observed, nor was there any identifiable molecular 
ion present. These mass spectral results implied that the new compound had the same 
kaurene aglycone as wedeloside (17) and that the additional 80 mass unit substituent 
must be on the glycosidic portion. 
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Figure 3.4. Negative FAB-MS of 4'-0-sulfated wedeloside (53) 
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Table 3.2. 13C NMR data for CATR (18), WED (17) and the wedeloside analogues 
(40), (41) and (53) 
C (17) 126 (53) (18)101 (40)100 (41)100 
(CD30D) (D20) (D20) (D20) (CD30D) 
1 48.1 47.0 46.9 47.2 46.4 
2 73.5 73.7 74.7 75.3 73.3 
3 41.0 40.2 39.9 42.9 41.2 
4 59.0 61.0 60.2 61.0 59.1 
5 49.8 51.8 51.6 52.2 51.7 
6 24.0 23.3 - 23.1 23.4 24.0 
7 35.8 35.1 35.1 35.1 35.9 
8 46.7 46.2 47.7 47.2 46.9 
9 53.5 52.1 53.1 51.9 53.8 
10 40.0 40.4 40.3 40.4 41.2 
11 20.9 19.8 18.3 20.2 21.0 
12 41.0 38.8 32.5 40.5 40.2 
13 79.5 79.8 42.4 79.8 79.7 
14 43.9 42.8 36.3 45.8 45.4 
15 82.2 81.5 82.6 81.5 82.4 
16 160.4 158.9 158.0 159.0 160.9 
17 108.9 109.3 108.9 109.3 108.8 
18 175.5 177.3 177.0 179.0 175.8 
19 175.5 177.3 178.0 179.4 175.3 
20 17.6 17.2 17.1 17.6 17.7 
1' 101.2 100.0 99.2 99.7 101.0 
2' 55.2 54.2 72.4 54.7 55.7 
3' 77.0 75.2 79.1 75.4 76.7 
4' · 69.6 74.8 74.5 76.5 76.3 
5' 77.4 75.0 74.8 74.7 75.9 
6' 62.2 61.1 60.9 61.0 62.0 
7' 175.5 175.5 174.0 177.3 175.3 
8' 46.7 45.8 43.6 46.2 46.7 
9' 27.2 26.8 25.6 26.7 27.2 
10' 22.9 22.4 22.4 22.3 23.0 
11 ' 22.9 22.2 22.2 22.4 23.0 
12' 174.2 172.7 - 175.4 172.1 
13 ' 31.5 30.3 - 35.8 48.2 
14' 36.6 35.6 - 38.9 71.2 
15' 141.7 141.4 - 141.3 145.2 
16', 20' 129.2 129.0 - 129.1 127.1 
17' 19' 129.2 129.5 - 129.7 129.4 
' 18' 127.1 127.2 - 124.1 128.6 
1" - - - 102.0 102.8 
2" - - - 70.7 72.0 
3" - - - 71.2 72.4 
4" - - - 72.7 73.9 
5" - - - 70.3 70.8 
6" -
- - 17.6 18.1 
85 
A+ m/z 651 
0 
(64) 
Figure 3.6. EIMS fragmentation of compound (64), the trimethylsilyl derivative of 
compound (53). 
The 1 H NMR spectrum of the compound was similar to those of the other 
wedeloside analogues.96,101 The 13C NMR spectrum (Table 3.2, Figure 3.7) 
indicated that (53) had the same number of carbon atoms as WED (17). The 
spectrum also showed the characteristic chemical shifts of the WED aglycone such as 
·the C-16 exocyclic methylene, the C-18, C-19 gem-diacid and the C-15, C-13 bearing 
the hydroxyl groups. The presence of the 3-phenylpropanoyl and the 3-methyl-1-
oxobutyl amine functionalities were also confirmed from the 13C NMR spectrum, 
supporting the GC-MS results following acid hydrolysis. However, there were 
differences between the chemical shifts of the C-3', C-4' and C-5' of the sugar in 
compound (53) and WED (17). Deshielding of C-4' ( +5 ppm) and shielding of C-3' (-
1 ppm) and C-5' (-2.4 ppm) were observed for compound (53), which is in agreement 
with the sulfate shift rules.127 This led us to propose the structure (53) with the 
sulfate group at C-4' accounting for the 80 mass units difference between WED and 
(53). 
18' 
160 140 120 100 80 60 
Figure 3.7. I3c NMR spectrum of 4'-0-sulfated wedeloside (53) 
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Confirmation of the presence of one sulfur atom in the molecule was 
attempted first by microanalysis. Although the presence of S was confirmed, the 
result obtained was low (S, found 3.0o/o, calc. 3.8% ), and the C, H, N values were also 
low. Since there was only a small amount of the compound isolated, and further 
biochemical studies were intended, HR negative FAB-MS was used for the 
determination of the elemental composition of the compound. The (M-H)- ion was 
accurately mass measured as 836.3163, corresponding to the composition 
C40H54NO 16S. This confirmed that-the new compound was wedeloside with an 
additional sulfate group at C-4' and led to the assignment of structure (53) for the 
compound. 
The presence of three acid groups (two carboxyl and one sulfate) makes the 
compound (53) very interesting for studying structure-activity relationships in 
mitochondrial ADP/ ATP transport as was discussed in the introduction. It has the 
WED skeletal system, yet the presence of the sulfate group on the glycoside similar 
to that in CATR (18) may enhance its biological activity as compared to that of WED 
(17) and the other analogues. 
In summary, further investigation of the plant W. asperrima for analogues of 
wedeloside revealed the presence of 4'-0-sulfated wedeloside (53). However, no 
analogues were isolated corresponding to the aglycone itself or glycosides lacking the 
side chain substituents. The fact that only compounds that showed toxicity were 
present indicated that these compounds are produced for a specific purpose, namely 
that these highly functionalized compounds could have evolved for the plant's 
defence against predators. 
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D. Microbial assay 
The compounds isolated from the dichloromethane and n-BuOH fraction 
were tested for anti-microbial activity. The three microorganisms used were the 
gram-positive bacteria Bacillus subtilis, gram-negative bacteria Escherichia coli and 
the yeast Saccharomyces cerevisiae. Results (Table 3.3) showed that the chalcones 
( 49) and (50) were active against B. subtilis and S. cerevisiae, but not their 
corresponding flavanone isomer. Compound (51) was also active against B. subtilis 
but not against the two other test organisms. The test also showed that both 
carboxyatractyloside (CATR, 18) and the new 4'-0-sulfated wedeloside (53) do not 
have anti-microbial activity. 
It was not surprising that the chalcones showed some anti-microbial activity. 
It has been reported that the presence of the a, P-unsaturated ketone functionality in 
chalcones is responsible for their biological activity .128 
Table 3.3. Distance of zone inhibition (in mm) of the three microorganisms by the 
1 t d d ISO a e compoun s. 
Compound (50µg) E.coli B. subtilis S. cerevisiae 
(48) (-) (-) (-) 
(47) (-) (-) (-) 
( 49) and (50) (-) 3.5 1.0 
(50) (-) 3.0 0.5 
(51) (-) 1.0 (-) 
(52) (-) (-) (-) 
(53) (-) (-) (-) 
CATR (18) (-) (-) (-) 
Blank (-) (-) (-) 
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E. Experimental 
General experimental procedures are given in Chapter 2. 
1. Extraction and Purification 
Milled, air-dried stems and leaves of W. asperrima ( 170g) were extracted 
with ethyl acetate (l.2L) at room temperature by mechanical shaking. After filtration, 
the concentrated extract was adsorbed-on silica gel, and flash chromatography using 
hexane with increasing concentrations of EtOAc provided eight fractions. The first 
fraction was subjected to centrifugal TLC (CTLC) with 10% EtOAc/hexane yielding 
45.7mg of P-amyrin acetate (45) and 18mg of P-amyrone (46). CTLC of the second 
fraction using 5-20o/o EtOAc/hexane gave 15mg of P-amyrin (44). Purification of the 
other fractions was attempted by a combination of column chromatography and 
CTLC, but resulted in mixtures of phytosterols, based on the initial 1 H NMR and 
mass spectral data obtained, and were discarded. 
The plant residue was soaked in 1: 1 MeOH/H20 (800 mL) and kept at 5°C 
for two months. After filtration, the concentrated extract was partitioned between 
· hexane and water. The aqueous mixture was then extracted successively with 
dichloromethane and n-BuOH. The less polar components of the dichloromethane 
and hexane extracts were discarded, while the more methanol-soluble ones were 
passed through a polyvinylpolypyrrolidone (PVP, also known as cross-linked 
polyvinylpyrrolidone129) column using 80% EtOAc/MeOH as eluent yielding five 
main fractions. Fractions containing compounds ( 47), ( 48), ( 49) and (SO)were further 
purified by RP-HPLC. A gradient of 45-60% MeOH/H20 over 25 min at 2.0 ml/min 
yielded ( 47) after 16.5 min and ( 48) after 17.9 min. The mixture of the chalcones 
(49) and (50) eluted after 21.7 min using a gradient of 85-90% MeOH/H20 over 25 
min at 3.0 ml/min. 
The methanol-soluble components of the n-BuOH extract was 
chromatographed on a Sephadex LH-20 column (MeOH) and yielded four major · 
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fractions. RP-HPLC of the first fraction using a gradient running from 30-10% 
H20/MeOH over 15 min resulted in the mixture of (40) and (41) eluting after 5.6 
min, and the pure compound (53) after 6.5 min. 
The last fraction obtained on gel chromatography was purified by RP-HPLC 
using 15o/o H20/MeOH as solvent. The chalcone (50) was eluted after 10.7 min 
while the glycosides (51) and (52) first eluted as a mixture after 8.07 min, and upon 
repeated RP-HPLC gave the pure compounds. 
A second extraction of the plant residue with MeOH/H20 ( 1: 1) was carried 
out, and the subsequent purification steps applied were similar to those used for the 
first aqueous methanol extract, except for the gel chromatography of the n-BuOH 
fraction. Purification of the second n-BuOH extract was attempted using droplet 
countercurrent chromatography (DCCC). The TLC behavior of the mixture in 
different solvent systems of varying compositions of CHCl3/MeOH/H20 and 
CHCl3/MeOH/n-PrOH/H20 were checked in selecting the most appropriate solvent 
for DCCC. The mixture of 5:6: 1 :4 CHCl3/MeOH/n-PrOH/H20 was chosen since it 
resulted in the elution of all the components in the mixture with Rf values around 0.4 
and above.109 The upper aqueous layer was used as the stationary phase and the 
lower water-saturated organic layer, the mobile phase. Six major fractions were 
obtained which where further purified by passing through Sephadex LH-20. The 
partially purified fractions were checked by RP-HPLC under the same conditions as 
in the purification of the wedeloside analogues, and did not result in pure compounds. 
Initial 1 H NMR of the mixtures showed that none of the components were similar to 
those of WED. 
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2. Natural Products 
a. Amyrins 
{3-Amyrin acetate, 12-0leanen-3{3-acetate (45), (45.7mg). Rf 0.57, lOo/o 
EtOAc/hexane as developing solvent. Colorless, needle-like crystals, m.p. 240-
2420C (lit.130 238-239°C). EIMS m/z 468 (M+, 3% ), 257 (2), 218 ( 100), 203 (38). 
13C NMR (CDCl3, 75.5 MHz) 15.6 (C-25), 16.7 (C-26), 16.8 (C-24), 18.2 (C-6), 
21.3 (OCOCH3), 23.4 (C-11), 23.6 CC-30), 23.7 (C-2), 25.9 (C-27), 26.1 (C-16), 
26.9 (C-28), 28.0 (C-23), 28.4 (C-15), 31.1 (C-20), 32.5 (C-17), 32.6 (C-7), 33.3 (C-
29), 34.7 (C-21), 36.8 (C-10), 37.1 (C-22), 37.7 (C-4), 38.2 (C-1), 39.8 (C-8), 41.7 
(C-14), 46.8 (C-19), 47.2 (C-18), 47.5 (C-9), 55.2 (C-5), 80.9 (C-3), 121.6 (C-12), 
145.2 (C-13), 171.0 (OCOCH3). 
{3-Amyrone, 12-0leanen-3-one, (46) (18mg). Rf 0.52, lOo/o EtOAc/hexane 
as developing solvent. M.p. 178-179°C (lit.130 177-179°C). Accurate mass 
measurement gave M+, Cale. 424.3703, C30H4gO requires 424.3705; mlz 218 calc. 
218.2036, C16H26 requires 218.2035. EIMS mlz 424 (M+, 6%), 409 (4), 218 (55), 
203 (27), 189 (12). 13C NMR (CDCl3, 75.5 MHz) 15.2 (C-25), 16.7 (C-26), 19.6 (C-
6), 21.5 (C-24), 23.6 (C-11), 23.7 (C-30), 25.9 (C-27), 26.1 (C-16), 26.5 (C-23), 26.9 
(C-28), 28.4 (C-15), 31.1 (C-20), 32.1 (C-17), 32.5 (C-7), 33.3 (C-29), 34.2 (C-2), 
34.7 (C-21) , 36.7 (C-10), 37.1 (C-22) , 39.3 (C-1) , 39.8 (C-8), 41.8 (C-14), 46.8 (C-
19), 46.9 (C-9), 47.3 (C-18), 47.5 (C-4) , 55.3 (C-5), 121.5 (C-12), 145.3 (C-13 ), 
217.9 (C-3). 
/3-Amyrin, 12-0leanen-3{3-ol (44), (15mg). Rt 0.26, 10% EtOAc/hexane as 
developing solvent. M.p. 196-197°C (lit.1 30 197-197.5°C). EIMS m/z 426 (M+, 9%), 
411 (5), 218 (100), 203 (36), 189 (16). 13C NMR (CDCb , 75.5 MHz) 15.5 (C-24), 
15.6 (C-25), 16.8 (C-26), 18.4 (C-6), 23.5 (C-11 ), 23.7 (C-30), 26.0 (C-27), 26.2 (C- · 
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15), 26.9 (C-16), 27.2 (C-2), 28.1 (C-23), 28.4 (C-28), 31.1 (C-20), 32.5 (C-17), 32.7 
(C-7), 33.3 (C-29), 34.7 (C-21), 37.0 (C-10), 37.1 (C-22), 38.6 (C-4), 38.8 (C-1), 
39.8 (C-8), 41.7 (C-14), 46.8 (C-19), 47.2 (C-18), 47.6 (C-9), 55.2 (C-5), 79.0 (C-3), 
121.7 (C-12), 145.2 (C-13). 
b. Chalcones and Flavanones 
7,4 '-Dihydroxy-8,3 '-dimethoxyflavanone ( 4 7), 5mg, m.p. 149-150°C. 
Accurate mass measurement gave M+, calc. 316.0947. C17H1606 requires 316.0945. 
m/z 167, calc. 167.0344. CgH704 requires 167.0345. m/z 150, calc. 150.0681. 
C9H1002 requires 150.0681. UV Amax 284, 320 (MeOH), 253, 338 dee. (MeOH + 
NaOMe), 256, 338 dee. (MeOH + NaOAc), 285, 320 (MeOH + NaOAc + H3B03), 
284, 320 (MeOH + AICI3), 284, 320 (MeOH + AICI3 + HCI). EIMS m/z 316 (M+, 
17%), 167 (86), 150 (99), 138 (84). lH NMR (8, CD30D, 300 MHz) 2.84 (dd, lH J 
3,17, H-3eq), 3.19 (dd, lH J 13, 17, H-3ax), 3.91 (s, 3H, 3'-0CH3), 3.97 (s, 3H, 8-
0CH3), 5.53 (dd, lH J 3, 13, H-2ax), 6.64 (dd, lH J 9, H-6), 6.92 (d, lH J 8, H-5'), 
7.06 (dd, lH J 2, 8, H-6'), 7.23 (d, lH J 2, H-2'), 7.61 (d, lH J 9, H-5) . 13C NMR 
. (CD30D, 75.5 MHz) 44.9 (C-3), 56.5 (3'-0CH3), 60.8 (8-0CH3), 81.5 (C-2), 111.3 
(C-6), 112.1 (C-10), 115.7 (C-2'), 116.2 (C-6'), 120.5 (C-5'), 124.0 (C-5), 132.1 (C-
l'), 136.9 (C-8), 148.2 (C-4'), 149.2 (C-3'), 157.8 (C-9), 159.8 (C-7), 193.6 (C-4). 
7,4 '-Dihydroxy-3 '-methoxyflavanone (48), 7.4mg. Accurate mass 
measurement gave M+, calc. 286.0841. C16H1405 requires 286.0840. m/z 137, calc. 
137.0239. C7H503 requires 137.0239. m/z 150, calc. 150.0681. C9H1002 requires 
150.0681. UV Amax 277, 312 (MeOH), 253, 335 dee. (MeOH + NaOMe), 253, 335 
dee. (MeOH + NaOAc), 278, 311 (MeOH + NaOAc + H3B03), 277, 312 (MeOH + 
AICI3), 277, 311 (MeOH + Al Cb + HCI). EIMS m/z 286 (M+, 26o/o ), 163 (10), 150 
(65), 137 (100). lH NMR (8, CD30D, 300 MHz) 2.79 (dd, lH J 3, 17, H-3eq) , 3.18 
I I 
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(dd, lH J 13, 17, H-3ax), 3.44 (s, 3H, 3'-0CH3), 5.47 (dd, lH J 3, 13, H-2ax), 6.44 
(d, lH J 2, H-8), 6.58 (dd, lH J 2, 9, H-6), 6.91 (d, lH J 8, H-5'), 7.02 (dd, lH J 2, 8, 
H-6'), 7.18 (d, lH J 2, H-2'), 7.82 (d, lH J 8, H-5). 13C NMR (CD30D, 75.5 MHz) 
45.1 (C-3), 56.4 (3'-0CH3), 81.3 (C-2), 103.9 (C-8), 111.2 (C-2'), 112.1 (C-6), 114.7 
(C-10), 116.1-(C-6'), 120.5 (C-5'), 129.8 (C-5), 132.0 (C-1'), 148.0 (C-4'), 149.1 (C-
3'), 165.6 (C-9), 167.7 (C-7), 193.5 (C-4). 
2 ',4',4-Trihydroxy-3-methoxychalcone (49), 9.4mg as mixture with (50), 
Spectral data obtained after comparison with (50). Accurate mass measurement gave 
M+, calc. 286.0841. C16H1405 requires 286.0840. mlz 137, calc. 137.0239. C7H503 
requires 137.0239. mlz 150, calc. 150.0681. C9H1002 requires 150.0681. EIMS m/z 
286 (M+, 12%), 150 (36), 137 (49). lH NMR (8, CD30D, 300 MHz) 3.93 (s, 3H, 3-
0CH3), 6.28 (d, lH J 2, H-3'), 6.40 (dd, lH J 2, 9, H-5'), 6.84 (d, lH J 8, H-5), 7.21 
(dd, lH J 2, 8, H-6), 7.36 (d, lH J 2, H-2), 7.63 (d, lH J 15, H-a), 7.77 (d, lH J 15, 
H~~), 8.01 (d, lH J 9, H-6'). 13C NMR (CD30D, 75.5 MHz), see Table 3.1. 
2 ',4 ',4-Trihydroxy-3 ',3-dimethoxychalcone (50), 4.8mg. Accurate mass 
measurement gave M+, calc. 316.0947. C17H1606 requires 316.0961. mlz 167, calc. 
167.0344; CgH704 requires 167.0332. m/z 150, calc. 150.0681, C9H1002 requires 
150.0681. UV Amax 271, 341 (MeOH), 272, 398 (MeOH + NaOMe), 271, 353 
(MeOH + NaOAc), 271, 344 (MeOH + NaOAc + H3B03), 279, 365 (MeOH + 
AlCl3), 281, 361 (MeOH + AlCl3 + HCl). EIMS m/z 316 (M+, 26% ), 167 (85), 150 
(100), 138 (71). lH NMR (8, CD30D, 300 MHz) 3.93 (s, 3H, 3-0CH3), 3.97 (s, 3H, 
3'-0CH3), 6.47 (d, lH J 9, H-5'), 6.84 (d, lH J 9, H-5), 7.22 (dd, lH J 2, 9, H-6), 
7.37 (d, lH J 2, H-2), 7.64 (d, lH J 15, H-a), 7.80 (d, lH J 15, H-~), 7.83 (d, lH J 9, 
H-6'). 13C NMR (CD30D, 75.5 MHz), see Table 3.1. 
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4'-0-/3-D-Glucopyranosyl-2 ',4-dihydroxy-3-methoxychalcone (51), 0.4mg. 
EIMS m/z 286 (A+, 8%), 150 (65), 137 (97). Negative FAB-MS m/z 447.0 (M-H)-. 
UV Amax 265, 379 (MeOH), 284, 453 (MeOH + NaOMe), 282, 461 (MeOH + 
NaOAc), 265, 381 (MeOH + NaOAc + H3B03), 273, 443 (MeOH + AlCb), 273, 434 
(MeOH + AlCl3 + HCl). lH NMR (8, CD30D, 300 MHz) 3.5-4.0 (m, 6H, H-2"-H-
6"), 4.04 (s, 3H, OCH3), 5.13 (dt, lH J 7, H-1"), 6.72 (d, lH J 2, H-3'), 6.79 (dd, lH 
J 2, 9, H-5'), 6.94 (d, lH J 8, H-5), 7.34 (dd, lH J 2, 8, H-6), 7.49 (d, lH J 2, H-2), 
7.79 (d, lH J 15, H-a), 7.94 (d, lH I 15, H-P), 8.24 (d, lH J 9, H-6'). 13c NMR 
(CD30D, 75.43 MHz), see Table 3.1. 
4 '-0-/3-D-Glucopyranosyl-2 ', 4-dihydroxy-3 ', 3-dimethoxychalcone (52) 
0.7mg. Positive FAB-MS m/z 479 MH+, calc. 479.1553. C23H27011 requires 
479.1554, m/z 317 AH+. Negative FAB-MS mlz 477 (M-H)·, 315 (A-H)-. EIMS m/z 
316 (A+, 19o/o), 167 (91), 150 (81). UV Amax 265, 379 (MeOH), 291,453 (MeOH + 
NaOMe), 291, 465 (MeOH + NaOAc), 316, 380 (MeOH + NaOAc + H3B03), 271, 
434 (MeOH + AlCl3), 273, 408 (MeOH + AlCl3 + HCl). 1 H NMR (8, CD30D, 300 
MHz) 3.5-4.0 (m, 6H, H-2"-H-6"), 3.98 (s, 3H, OCH3), 4.04 (s, 3H, OCH3), 5.20 (dt, 
lH J 7, H-1"), 6.93 (d, lH J 9, H-5'), 6.95 (d, lH J 8, H-5), 7.35 (dd, lH J 2, 8, H-
6), 7.49 (d, lH J 2, H-2), 7.78 (d, lH J 15, H-a), 7.96 (d, lH J 15, H-P), 8.06 (d, lH 
J 9, H-6'). 13C NMR (CD30D, 75.43 MHz), see Table 3.1. 
c. Synthesis of Flavanone ( 47) and Chalcone (50) 
4-Benzyloxy-3-methoxybenzaldehyde (59). To a solution of vanillin, (0.02 
mol, 3.043g) in acetone (120 ml) was added anhydrous K2C03 (9.52g) and benzyl 
bromide (0.022 mol, 3.76g), and the reaction mixture stirred at 60°C for 24 h under 
N2. The mixture was poured into cold, dilute HCl and extracted with chloroform. 
The organic phase was washed with water and saturated brine, dried (MgS04) and 
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concentrated at reduced pressure. Flash chromatography (Si02 eluting with 20o/o 
EtOAc-pet spirit) gave the benzylated vanillin ( 4.5 lg, 93.2% yield) as a clear oil 
which solidified on cold storage, m.p. 63-65°C (lit131 64-65°C). C15H1403 requires 
C 74.4, H 5.82%. Found C 74.17, H 5.85%. lH NMR (8, CDCb, 300 MHz) 3.93 (s, 
3H, OCH3), 5.22 (s, 2H, OCH2Ph), 6.97 (d, lH J 7.8, H-2), 7.23-7.41 (m, 7H, H-2'-
H-6', H-5, H-6), 9.82 (s, lH, ArCHO). 13C NMR (CDCl3, 75.5 MHz) 55.9 (O-CH3), 
70.7 (OCH2Ph), 109.2 (C-2), 112.2 (C-5), 126.5 (C-6), 127.1 (C-3', C-5'), 128.1 (C-
4'), 128.6 (C-2', C-6'), 130.1 (C-1), 1-35.9 (C-1'), 149.9 (C-3), 153.4 (C-5), 190.8 
(CHO). 
2,3,4-Trihydroxyacetophenone, gallacetophenone (56).117 Pyrogallol (0.01 
mol, 1.26g) and acetic anhydride (0.95 ml) were heated with Amberlite resin IR-
120130 (45% by weight of pyrogallol) at 155°C for 24 h. The solution was then 
cooled and added with ethanol. The mixture was filtered through cotton and the 
filtrate added with 5 drops cone HCl. The resulting solution was refluxed for 25 min, 
cooled, the solvent evaporated under vacuum and the resulting solids dried. The 1 H 
NMR showed mainly two compounds, the starting material and the desired product 
(1.39 g, 83% yield, m.p. 168-170°C, lit.117 169-171 °C). The mixture was separated 
by passing through a PVP column eluting with 50% aqueous MeOH. TLC Rf 0.49 
using 50% light petroleum/EtOAc. 1 H NMR (8, CD30D, 300 MHz) 2.56 (s, 3H, 
COCH3), 6.44 (d, lH J 8.9, H-5'), 7.33 (d, lH J 8.9, H-6'). 
4'-Benzyloxy-2 ',3 '-dihydroxyacetophenone (57).120 To a solution of 
gallacetophenone (0.007 mol, 1.20g) in DMF (18 ml) were added LiiC03 (0.007 
mol, 0.59g) and benzyl bromide (0.1 mol, 1.17 ml) dropwise. The resulting 
suspension was stirred under N2 at 60°C for 24 hrs. The reaction mixture was poured 
into cold, dilute HCl and extracted with chloroform. The organic phase was washed 
with water and saturated brine, dried (MgS04) and concentrated under reduced 
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pressure. The mixture was separated by repeated column chromatography using PVP 
and eluting with methanol. The product was obtained as yellow solids, 0.90g, 49o/o 
yield, m.p. 136-137°C, lit.120 137-138°C. lH NMR (3, CDCb, 300 MHz) 2.53 (s, 
3H, COCH3), 5.20 (s, 2H, OCH2Ph), 6.51 (d, lH J 9, H-5'), 7.24 (d, lH J 9, H-6'), 
7.34-7.43 (m, 5H, ArH), 12.52 (s, bonded 2'-0H). 13C NMR (CDCl3, 75.5 MHz) 
26.7, 71.3, 104.7, 115.2, 122.8, 127.8, 128.7, 129.1, 134.1, 136.3, 150.9, 151.4, 
208.9. 
4'-Benzyloxy-2 '-hydroxy-3 '-methoxyacetophenone (58)120. A solution of 
benzylated gallacetophenone (57) (0.0024 mol, 0.63 lg) in dry acetone (20 ml) was 
added to K2C03 (2.2 ) under N2. Dimethyl sulfate (0.23 ml) was added in batches 
and the mixture stirred for 20 hrs at 5°C. The mixture was filtered and the residue 
washed with acetone. The filtrate on evaporation gave a pale yellow solid which was 
ran through a PVP column using MeOH as eluent. The monomethylated product was 
obtained as a yellow solid, 0.5976g, 90% yield, m.p. 143-145°C, lit120 146°C. TLC 
Rf 0.52 using 30o/o EtOAc/light petroleum as developing solvent. EIMS m/z 272 
(M+, 2%), 230 (1), 153 (1), 135 (1), 91 (100). lH NMR (3, CDCl3, 300 MHz) 2.56 
(s, 3H, COCH3), 3.90 (s, 3H, OCH3), 5.22 (s, 2H, OCH2Ph), 6.51 (d, lH J 9.2, H-5'), 
7.39-7.40 (m, 5H, ArH). 7.44 (d, lH J 9, H-6'), 12.59 (s, lH, bonded 2'-0H). 13C 
NMR (CDCl3, 75.5 MHz) 26.4, 60.7, 70.6, 104.6, 115.4, 126.8, 127.1, 128.2, 128.7, 
136.2, 137.0, 157.3, 157.6, 203.2. 
4',4-Dibenzyloxy-2 '-hydroxy-3 ',3-dimethoxychalcone (60) .133 To a 
solution of the protected acetophenone (58) (0.0019 mol, 0.51 g) in ethanol (30 ml) 
~nd 40% aq NaOH (18 ml) was added the benzylated vanillin (59) (0.0019 mol, 
0.45g) while keeping the reaction temperature between 0-5°C. The solution was 
stirred at this temperature for 2h, then at room temperature for 7 days. The mixture 
was neutralized using cold lOo/o HCl, and then extracted with dichloromethane. The 
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organic extract was washed with satd. NaHC03 and water, dried (MgS04) and 
reduced under vacuum. The residue was passed through a silica gel column using 
4: 1 :5 CH2Cl2/EtOAc/light petroleum as eluting solvent. The first compound eluted 
was the recovered starting acetophenone (58), then the desired condensation product 
(60) (0.723g, 79o/o yield) and the reduced vanillin, a side product from the Cannizzaro 
reaction of the starting aldehyde (59). Compound (60), m.p. 133-135°C. C13H2g06 
requires C 75.0, H 5.7%. Found C 74.7, H 5.9%. EIMS m/z 496.3 (M+, 25%), 177 
(12), 91 (100). lH NMR (8, CDCl3, 3QO MHz) 3.96 (s, 6H, 3'-0CH3, 3-0CH3), 5.23 
(s, 2H, OCH2Ph), 5.26 (s, 2H, OCH2Ph), 6.55 (d, lH J 9, H-5'), 6.92 (d, lH J 9, H-
5), 7.17 (dd, lH J 2, 9, H-6), 7.35-7.47 (m, 12 H, 2 x 5 ArH, H-2', H-a), 7.64 (d, lH 
I 9, H-6'), 7.84 (d, lH J 15, H-p). I3c NMR (CDCl3, 75.5 MHz) 56.1 (3-0CH3), 
60.1 (3'-0CH3), 70.7 (OCH2Ph), 70.8 (OCH2Ph), 104.5 (C-5'), 110.7 (C-2), 113.3 
(C-1'), 115.7 (C-5), 117.9 (C-a), 123.2 (C-6), 125.7 (C-1), 127.1 (C-2", C-6"), 127.2 
(C-2", C-6"), 128.0 (C-4"), 128.2 (C-4"), 128.7 (C-3", C-5"), 128.8 (C-3", C-5"), 
136.3 (C-1"), 136.4 (C-1"), 137.1 (C-3'), 144.9 (C-4), 150.8 (C-3), 157.5 (C-4'), 
158.5 (C-2'), 192.3 (C-W). 
7,4'-Dibenzyloxy-8,3'-dimethoxyflavanone (61).121 To a solution of the 
chalcone (60) (0.114 mmol, 0.0566 g) in ethanol (20 ml), was added 5 drops of 85% 
H3P04, and the mixture refluxed for 24 h. The solution was concentrated under 
reduced pressure and the residue dissolved in CH2Cl2. The organic extract was 
washed with satd NaHC03 and water, dried (MgS04) and concentrated under 
vacuum. The residue was passed through a silica gel column using 20% EtOAc/light 
petroleum as eluent to yield the recovered starting material ( 60) in the first fraction, 
while the second fraction yielded the flavanone product (61) (0.337g, 60% yield), Rf 
0.34 using 30o/o EtOAc/light petroleum as developing solvent. Compound (61), m.p. 
40-42°C. C13H2g06 requires C 75.0, H 5.7%. Found C 75.0 H 5.4%. EIMS m/z 
496.3 (M+, 20%), 269 (49), 177 (8), 91 (100). lH NMR (8, CDCl3, 300 MHz) 2.85 
(dd, lH J 3, 17, H-3eq), 3.02 (dd, lH J 12, 17, H-3ax), 3.87 (s, 3H, 3'-0CH3), 3.90 (s, 
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3H, 8-0CH3), 5.16 (s, 2H, OCH2Ph), 5.20 (s, 2H, OCH2Ph), 5.44 (dd, lH J 3, 12, H-
2ax), 6.66 (d, lH J 9, H-6), 6.88 (d, lH J 8, H-5'), 6.92 (dd, lH J 2, 8, H-6'), 7.04 (d, 
IH J 2, H-2'), 7.29-7.44 (m, lOH, 2 x 5 ArH), 7.62 (d, lH J 9, H-5). 13C NMR 
(CDCl3, 75.5 MHz) 44.2 (C-3), 56.2 (3'-0CH3), 60.5 (8-0CH3), 70.7 (OCH2Ph), 
70.8 (OCH2Ph), 79.5 (C-2), 107.4 (C-10), 109.8 (C-6), 110.7 (C-2'), 113.5 (C-5'), 
116.3 (C-6'), 118.4 (C-5), 122.6 (C-8), 127.0 (C-2", C-6"), 127.1 (C-2", C-6"), 127.8 
(C-4"), 128.0 (C-4"), 128.5 (C-3", C-5"), 128.6 (C-3", C-5"), 131.7 (C-1 '), 136.1 (C-
l"), 136.8 (C-1"), 148.3 (C-3'), 149.6 (C-4'), 155.5 (C-9), 157.8 (C-7), 190.9 (C-4). 
Debenzylation of protectedflavanone (61). 125 Hexamethyldisilane (100 µl) 
was added to I2 (0.21 mmol, 0.053g) in a flame-dried flask fitted with a condenser 
under N2. The mixture was heated at about 55°C for 2 h until a colorless solution 
was formed. The protected flavanone (61) (0.05 mmole, 26.2mg) in dry CCl4 was 
then added at room temperature and the mixture stirred for 24 h while maintaining the 
temperature of the reaction between 30-35°C. The reaction was quenched with 
MeOH and then .concentrated under reduced pressure. The residue was dissolved in 
EtOAc and washed with sodium bisulfite and water, then dried. Evaporation of the 
solvent and initial purification by passing through a short RP C-18 column using 10% 
H20/MeOH as eluent resulted in partially purified fractions. Re-chromatography on 
silica gel of the second and third fractions using 70% EtOAc/light petroleum as 
eluent yielded the monodebenzy lated product ( 2 mg, 1 Oo/o) and then the fully 
deprotected products (6 mg, 38%) which was a mixture of the flavanone ( 47) and its 
chalcone isomer (50). Accurate mass measurement gave M+, calc. 316.0947. 
C17H1606 requires 316.0945. lH and 13C NMR spectral data corresponded to the 
spectral data of the natural products (47) and (50) as detailed (Section D.2.b). EIMS 
m/z 316 (M+, 49%), 167 (64), 150 (45), 91 (100). 
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d. W edeloside and its Analogues 
4'-0-Sulfated wedeloside (53), (16mg). Negative FAB-MS mlz 836.3182 
(M-H)-, (Calcd. for C40H54N016S, 836.3163) 792 (M-H-C02)·. lH NMR (8, 
CD30D, 300 MHz), selected values. Assignments based on published data for 
related structures. IOI, 96 0.84 (br s, 3H, H-10), 0.89 (br s, 3H, H-11 '), 1.00 (s, 3H, H-
20), 3.76 (s, lH, H-15), 4.32 (d, lH 17.2, H-1'), 5.20 (s, lH, H-17), 5.23 (s, lH, H-
17), 7.14 (br dt, lH J 7, 1.8, H-18'), 7)1 (br tm, 2H J 7, H-17', H-19'), 7.34 (dm, 2H 
J 7, H-16', H-20'). Be NMR, see Table 3.2. 
4'-0-Rhamnosyl wedeloside mixture (40) and (41), 17mg. Compound (40), 
negative FAB-MS m/z 902 (M-H)-, 858 (M-H-C02)-. Compound (41), negative 
FAB-MS m/z 918 (M-H)·, 874 (M-H-C02)·. Be NMR, see Table 3.2. 
Silylated derivative of 4'-0-sulfated wedeloside (53). The compound 
(1.0mg) was suspended in dry pyridine (10µ1) and treated with bis (trimethylsilyl) 
trifluoroacetamide + 10% trimethylchlorosilane (BSTFA-TMCS, 9:1) (50µ1) at 70°C 
to give the per-TMSi derivative (64). An aliquot of the mixture was subjected to 
direct probe EI-MS. Significant ions above m/z 600: m/z 1114 (34%), 998 (18), 958 
(22), 842 (12), 728 (25), 651 (100). 
Hydrolysis of 4'-0-sulfated wedeloside (53). The sample (0.5mg) was 
dissolved in 0.5 ml MeOH. A portion (100 µl) of this solution was heated with 4M 
HCl/water (200µ1) for 2h and then evaporated to dryness (under N2, then under 
vacuum). The residue was dissolved in acetonitrile (10µ1) to which was added 
BSTFA-TMCS (9: 1) (50 µI). The solution was then heated at 70°C for 20 min. The 
silylated hydrolysis products were analyzed by GC-MS (100-250°C, LilO). Two 
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major hydrolysis products were identified by comparison of their mass spectra and 
ret~ntion times with published mass spectra32: TMSi-3-phenylpropanoate (62) and 
compound (63) (Figure 3.5). 
3. Microbial Assay 
a. Preparation of the Microbial Culture134 
The microorganisms used were Bacillus subtilis (gram positive), Escherichia 
coli (gram negative) and Saccharomyces cerevisiae (yeast). The bacteria were grown 
on a Mueller Hilton medium and the fungus on Sabouraud's Agar medium. The 
inoculum was pipetted into sterile Petri dish and 15-20 ml molten agar at 45°C was 
added. The plate was carefully rotated to mix agar and inoculum, and the agar was 
allowed to set. 
b. Filter Paper Disc Diffusion Plate Method 
The sample was dissolved in an appropriate solvent. An aliquot equivalent 
to 50µg of pure compound and lOOµg of crude mixture was used to wet a 0.25 in 
. filter paper disc. The discs were dried and then placed on the inoculated plate. Three 
trials were ran for each sample per test organism. The plates were inoculated at 28 °C 
for 25 hrs after which the zone of growth inhibition was measured. Methanol was 
used as the blank. 
CHAPTER IV 
A 
CHEMICAL STUDY 
OF THE PHILIPPINE MEDICINAL 
PLANT 
WEDEL/A PROSTATA JACQUIN 
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A. Introduction 
1. Selection of the Plant Material 
The choice of the starting biological material 1s always an important 
consideration in the strategic approach for the search of potentially bioactive 
metabolites. As was briefly mentioned in Section LC, selection can be based on 
taxonomic, chemotaxonomic and ethnopharmacological considerations, or by random 
choice. 
In the random approach, all available species are collected, irrespective of 
prior knowledge and experience on the use of the plant. An example is in the 
anticancer drug discovery program of the National Cancer Institute (U.S.) where 
initially around 35,000 plants were collected randomly. The plant extracts were then 
screened primarily against L1210 and P388 mouse leukemia tumour systems.135 In 
the taxonomic approach, plants of a predetermined taxa are sought from diverse 
locations because of interest on specific compounds and their analogues .. One such 
case is the evaluation of Taxus species in the search of taxol and its co-metabolites. 
A slight variation is the chemotaxonomic approach, where plants that are thought to 
contain related compounds of a certain class (e.g. pyrrolizidine alkaloids) are 
collected. In the ethnopharmacological (or ethnomedical) approach, the surviving 
oral or written information on the therapeutic properties of the plant is evaluated. The 
plants that are viewed as being likely to yield interesting new compounds for 
potential development are then chosen. 
The ethnomedical approach has been very popular in recent years in 
selecting plants for natural products study. Plants used in folk medicine were not 
chosen by chance, but are the results of years of careful experimentation and 
painstaking observations. They have been part of tradition that has been handed 
down from one generation to another. Some traditionalists do not agree with the 
modern scientific approach of isolating pure active principles from medicinal plants 
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believing that the whole plant is necessary for the efficacy of the treatment. For 
example, according to the traditional Chinese medical philosophy, a formulation 
consists of four different components, namely, the principle, adjuvant, auxiliary and 
conductant.136 The principle provides the curative effect, the adjuvant helps 
strengthen the principle effect, the auxiliary relieves secondary symptoms or 
decreases the toxicity of the principle, and the conductant directs the action of the 
principle to the target organ or site. In their traditional recipe, each component may 
comprise more than one plant and the drug's optimal effectiveness is due to the 
combined action of the compounds in these plants. 
However, it cannot be denied that the scientific approach of screening 
medicinal plants for pure active metabolites has resulted in many cases in the 
development of new drugs. In lieu of this, it is important that studies of folk 
medicine and their documentation be carried out before the plants become extinct 
because of rapid loss of their natural habitat due to anthropogenic activities. In Africa 
for example, available information on their medicinal plants is often fragmented 
because of several centuries of continuous waves of invasion and conquest of various 
parts of the continent.137 
In the Philippines, there is also a dwindling use of folk medicine. In cases of 
sickness, most people would rather consult a medical doctor than visit a medicine 
man, locally known as "herbolario". Some people wilr only resort to folk medicine 
due to economic considerations, or when modem medicine does not work. Studies 
on Philippine medicinal plants have been encouraged by government agencies , such 
as the Department of Science and Technology, to identify possible active metabolites, 
not only for future development of new drugs but also to make folk medicine a more 
acceptable and cheaper alternative to modem drugs. 
In the study of medicinal plants , extracts that are studied are those which are 
closest in nature to the traditionally used medicinal products . Some folk medicinal 
formulations can often be prescribed as suspensions in coconut oil which might imply 
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that the active constituents are mainly lipophilic compounds. The most frequently 
used solvents in traditional medicines are water and ethanol, which may lead one to 
expect the presence of polar active principles. However, it is always worthwhile to 
keep in mind that aqueous extracts may contain a mixture of constituents that range 
from normal water-soluble compounds to poorly soluble, non-soluble and colloidally 
dispersed components. f38 Thus, even if an active compound is extractable with water 
and found in the crude aqueous extract, there is still the slight chance that in the pure 
form, it may tum out to be insoluble or poorly soluble in polar solvents. 
2. Related Studies on Wedelia prostata Jacquin 
In the present study, a Philippine medicinal plant Wedelia prostata Jacquin 
was investigated, not only for ethnotherapeutic considerations but also for 
chemotaxonomic reasons. Chemical studies on the polar fractions of several plants 
belonging to the genus Wedelia (e.g., W. glauca, W. asperrima, W. biflora) have 
resulted in the isolation of toxic kaurene glycosides such as atractyloside (30)81, the 
wedelosides (17)99, (40), (41)100, (53) and bifloratoxin (52)101 . 
. Chemotaxonomically, W. prostata could be expected to contain compounds of similar 
types to those isolated from the above Wedelia plants. However, W. prostata has 
been used in folk medicine in the Philippines without any reported cases of 
poisoning, which implied the possible absence of toxic compounds. It was the 
purpose of this chemical investigation to determine structures of possible biologically 
active metabolites, including atractyloside and wedeloside analogues, that might be 
present in the plant. This was also part of a continuing study on the chemical 
constituents of medicinal plants from the Philippines. 
W. prostata Jacquin (locally known as "Hagonoi "), is a coarse, herbaceous 
vine which grows profusely in areas close to beaches and along streams throughout 
the archipelago.139 It was introduced to the Philippines from Indonesia and has also 
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been found in India, China, Malaysia, West Polynesia and 1n tropical parts of 
Australia. 
The plant has been widely used in traditional medicine for treatment of 
diverse ailments from skin infections to coughs and uterine haemorrhages. The 
reported 140 medicinal applications of the plant are as follows: 
"The leaves are used for dyeing hair and promoting growth of hair. An 
infusion of the leaves is considered to act as a tonic, and used for the 
relief of coughs, cephalagia skin disease and alopecia. The seeds, 
flowers and leaves are used as decoction for the treatment of uterine 
haemorrhage and menorrhagia. 
The leaves are made into poultices for discolored skin, cuts, insect bites, 
ulcers, sores, swelling and varicose veins. The juice is prescribed in a 
mixture for chronic constipation. A decoction is recommended as an 
antiperiodic in malaria. The root can be used as cure for vaginal 
discharges, gonorrhoea and gravel. The leaves in decoction are anti-
scabious. A tea made from the roots and leaves is said to be a remedy for 
stomach ache. The plant is also useful as a febrifuge." 
A consideration of these folk medicinal applications led to the study of the 
terpenoid chemistry of the plant. Ragasa et. a[.141 investigated the chloroform extract 
of the plant which afforded (Figure 4.1) two known ent-kaurenic acids, one (66) of 
which possessed a tiglate ester function while the other (65) had a cinnamate ester 
group. Four new eudesmanolide sequiterpenes (67), (68), (69) and (70), were also 
isolated, which have substitution patterns similar to those compounds present in W. 
trilobata, 142 but differed significantly in their stereochemistries. A survey of the 
cytotoxicity of eudesmanolides showed that the basic structural requirement for this 
activity is the a-me thy lene-y-lactone moiety_ 143 The presence of this structural 
feature in the compounds (67) to (70) implies the possibility that these compounds 
. I 
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could be cytotoxic. However, the specific biological activity of these previously 
isolated compounds is yet to be determined. 
Since a study of the chloroform extract of the plant had been carried out, the 
present work concentrated on the more polar fractions, that is, those present in the 
MeOH/H20 extract, since most of the preparations of the plant used in traditional 
medicine were aqueous extracts. 
, 
RO' 
(65) R = 
Ph 
(66) R = H 
OAc OR 1 
: H 
R 1 = H (67) 
R1 = OAc (68) 
RI= H (.69) 
RI= OAc (70) 
Figure 4.1. Compounds isolated from the chloroform extract of W. prostata 
Jacquin.1 41 
B. Isolation and Structure Elucidation 
1. Isolation and Microbial Assay 
W. prostata (in its vegetative stage) was collected from the College of 
Forestry, University of the Philippines at Los Banos, Laguna and identified by Prof. 
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Pancho of the Department of Botany. The leaves were air-dried for one week, then 
oven-dried at 30°C overnight, and ground in a Wiley mill (30-40 mesh). 
The ground, dried leaves were extracted with 1: 1 MeOH/H20 twice with 
mechanical shaking at room temperature (Scheme 4.1). The resulting suspension was 
filtered and the filtrate concentrated in vacuo until most of the methanol had 
evaporated. The resulting aqueous residue was then extracted successively with 
hexane, dichloromethane, ethyl acetate and n-BuOH. The different extracts were 
tested for microbial activity against gram-positive (B. subtilis) and gram-negative 
(( E.coli) bacteria, and yeast (S. cerevisiae) (Table 4.1). The initial crude extract 
showed activity against gram-positive bacteria. Among the different fractions, the 
hexane, dichloromethane and ethyl acetate extracts also inhibited the growth of the 
gram-positive bacteria B. subtilis but not the other two test organisms. The absence 
of anti-microbial activity of the polar fractions did not rule out the possibility that 
they may possess a different form of biological activity. 
Table 4.1. Distance of zone inhibition (in mm) of the three microorganisms using the 
crude extracts. 
Extract ( 1 OOµg) E.coli B. subtilis S. cerevisiae 
initial (-) 2.0 (-) 
hexane (-) 2.0 (-) 
CH2Cl2 (-) 2.5 (-) 
EtOAc (-) 1.0 (-) 
n-BuOH (-) (-) (-) 
H20 (-) (-) (-) 
Blank (-) (-) (-) 
ground dried leaves 
of W. prostata 
residue 
soak in 1: 1 
MeOH/H20 
filter 
soak in 1: 1 
MeOHIH20 
filter 
filtrate 
concentrate 
in vacuo 
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aqueous 
residue 
(discard) 
filtrate 
aqueous 
mixture 
aqueous 
mixture 
extract with 
CH2Cl2 
extract with 
EtOAc 
aqueous 
mixture 
aqueous 
fraction 
extract with 
n-BuOH 
n-BuOH 
fraction 
(cont'd. on 
Scheme 4.2) 
EtOAc 
fraction 
mixture 
extract with 
hexane 
(71) 
hexane 
fraction 
concentrate 
under vacuum 
residue 
repeated Si gel 
chromatography 
mixture of kaurenoic 
acids (72) and (73) 
Scheme 4.1. General extraction and isolation procedure for W. prostata 
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2. Identification of Components 
a. Less Polar Hexane Fraction 
Repeated silica gel chromatography of the hexane soluble portion of the 
MeOH/H20 extract with increasing polarity of the solvent (using ethyl acetate/light 
petroleum) resulted in partially purified fractions. Final purification of the fractions 
containing the major components was carried out by HPLC using a Nitrile column 
and yielded the known compounds poriferasterol (71) and a mixture of the kaurenoic 
acids (72) and (73). 
HO 
2 
3 
4 6 
(-)ent-kaur- l 6-en- l 9-oic acid (72) 
12 
21 
18 20 
29 
16 
Poriferasterol (71) 
28 
25 
27 
26 
grandiflorenic acid (73) 
Poriferasterol (71 ) was identified by comparison of its melting point, 13C 
NMR and MS data with those described in the literature.144, 145 The mass spectrum 
of compound (71) had a molecular ion at mlz 412 and other significant ions which are 
characteristic of the fragment ions formed by either stigmasterol or poriferasterol 
upon ionization. 144 Other ions present in the spectrum were at m/z 397 (M+--terminal 
110 
isopropyl group); mlz 351 [M+·-(terminal isopropyl group+H20)]; m/z 300 
corresponding to the loss of part of the side chain; and mlz 271 corresponding to the 
loss of the side chain by cleavage of the C 17-C20 bond accompanied by loss of two 
hydrogen atoms from the ring system. 
The spectroscopic data obtained could not distinguish between stigmasterol 
and poriferasterol (71), which differ only in the absolute configuration at C24. 
Stigmasterol has a 24R configuration while poriferasterol is its 24S isomer. The 
optical rotations of the two isomers differed only slightly (lit146 [a]o -51 and -46 for 
stigmasterol and poriferasterol respectively), but the observed optical rotation of the 
sample [a]o -47 implied that the compound could be poriferasterol. The melting 
point (154°C) further confirmed the identity of the compound as poriferasterol (71) 
(litl44 m.p. 156°C) and not stigmasterol (lit144 m.p. 170°C). A review of the literature 
showed that poriferasterol is commonly found in sponges and algae, and that the 24R 
sterols such as stigmasterol are the ones that are usually present in the vast majority 
of higher plants. 
The other major component isolated from the hexane extract was a mixture 
(1.25: 1) of the known compounds (72) and (73). Their structures were determined by 
comparison of their 13C NMR and MS data with literature values.147, 148, 149 The 
mass spectrum of the mixture showed two molecular ions at m/z 302 and 300 which 
implied that the two compounds differed only by one degree of unsaturation. 
Examination of the 13C NMR spectrum revealed that the carbon signals could be 
assigned to two compounds. One of the compounds had the exocyclic methylene 
signals at 155.8 and 103.0 ppm and a carboxyl signal at 184.8 ppm. The other 
compound also had the carboxyl signal at 184.7 ppm, and the exocyclic methylene 
group at 158.5 and 105.5 ppm, but there were also the additional carbon resonances at 
155.9 and 114.9 ppm .for another pair of olefinic carbon atoms. The number of the 
carbon signals and the presence of the carboxy 1 groups and exocyclic double bonds 
implied that the two compounds were diterpenoic acids. Taking into consideration 
the 20 carbon atoms and the two oxygen atoms for the carboxyl group, the molecular 
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ion at m/z 302 could then be assumed to correspond to the molecular formula 
C20H3002, and the other molecular ion at mlz 300 the formula C20H2g02. 
Comparison of the 13C NMR spectra of the individual components of the 
mixture with literature data 147, 149 confirmed their identities as ent-kaur-16-en-19-oic 
acid (72) and grandiflorenic acid (73). These two known kaurenoic acids have been 
previously isolated as the free acids or their derivatives in several Wedelia species.150 
A review of the literature on their biological activity showed that they have been 
isolated from other medicinal plants such as Aspilia mossambicencis, l5 l Aspilia 
pluriseta,151 Aralia cordata Thunb.152 and Montanoa tomentosa,153 and found to be 
responsible for some of the bioactivities of these plants. 
Plants of Aspilia species have been used in traditional medicine in East and 
West Africa for the treatment of many ailments.151 Compound (72) has been isolated 
from A. pluriseta, and was reported to possess antibacterial and antihepatotoxic 
activity. A. mossambicencis has been employed as remedy for disorders particular to 
women such as galactogogue and to alleviate menstrual cramps. The leaves of the 
plant have also been observed to be consumed by female wild chimpanzees more 
frequently than males. Compounds (72) and (73) have been isolated from the plant 
and have been shown to exhibit uterostimulatory activity and might possibly possess 
pharmacological effects on the female reproductive system.151 
The two kaurenoic acids (72) and (73) have also been isolated from 
M ontanoa tomentosa. In Mexican traditional medicine, the aqueous extract of the 
leaves of the plant has been used as an abortifacient and for inducing labor in late 
stages of pregnancy. It has also been shown that grandiflorenic acid (73) but not 
kaurenoic acid (72) induces uterine contractions.153 
Kaurenoic acid (72) has been isolated from Aralia cordata, 152 a traditional 
Japanese medicinal plant used in remedies to produce analgesic effects. Compound 
(72) was shown to be significantly effective as an analgesic , in the treatment of 
I · 
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hypothermia, affects the duration of pentobarbital-induced anaesthesia, and depresses 
locomotor activity enhanced by methampetamine at a dose of 300 mg/kg. 
The reported bioactivities of the kaurenoic acids (72) and (73) isolated from 
the mentioned medicinal plants can probably account for some of the folk medicinal 
applications of W. prostata. The uterostimulatory effect of grandiflorenic acid (73) 
and its possible pharmacological effects on the female reproductive system could be 
the basis of the use of the plant for the treatment of uterine haemorrhages, 
menorrhagia and vaginal discharges. The presence of the kaurenoic acid (72) which 
exhibited analgesic activity could also be responsible for the use of W. prostata as 
anti-periodic in malaria and as a febrifuge. 
b. Polar Fractions 
The dichloromethane and ethyl acetate fractions of the MeOH/H20 extract 
were not studied further since a previous investigation of the chloroform extract of 
the plant has been carried out. Emphasis was then placed on the n-BuOH extract of 
the plant during the remaining time. 
To the residue obtained after concentration of the n-BuOH fraction was 
added EtOAc/MeOH (2:8) to separate initially the methanol-EtOAc soluble 
compounds from the most polar ones. The soluble components after removal of the 
solvent were passed through a Sephadex LH-20 column using MeOH/H20 (9: 1) as 
eluent and yielded partially purified fractions. These fractions were then passed 
through a short reverse-phase C-18 column and eluted first with MeOH/H20 (1:1) 
then with MeOH. Final purification using repeated RP-HPLC yielded compound 
(76). The most polar fractions were dissolved in water and passed through Sephadex 
LH-20 column using 1: 1 MeOH/H20 as eluent. The partially purified fractions 
obtained were then purified by repeated RP-HPLC to yield compounds (74), (75), 
(77) and (78) (Scheme 4.2). 
n-BuOH fraction 
from Scheme 4.1 
MeOH soluble 
compounds 
concentrate 
zn vacuo 
residue 
concentrate 
under 
vacuum 
residue 
I add EtOAc/MeOH (2:8) 
mixture 
filter 
residue 
dissolve in H 20 
pass through 
Sephadex LH-20 
MeOH/H2 0 (1: 1) 
as eluent 
fraction mixtures 
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pass through 
Sephadex LH-20 
MeOH/H20 (9: 1) 
as eluent repeated RP-HPLC 
fraction mixtures 
H20/MeOH 
(1: 1) 
mixture 
pass through 
short C-18 
column 
MeOH 
mixture 
repeated RP-HPLC 
partially purified fraction (76) 
(74) (75) (77) (78) 
Scheme 4.2. Purification of the n-BuOH fraction 
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OR 
6. __ 
2 3 
HO 
xyl(p) = HO.........,~ 
OH 
R = H (74) 
R = xyl(p) (75) 
R = unassigned (7 6) 
An examination of the 1 H NMR spectra of the compounds in d6-DMS0 
showed similarities of some of the signals in compounds (74), (75) and (76). The Be 
NMR spectra of the three compounds (Table 4.2) also exhibited similar resonances in 
the aromatic region, for the glycosidic carbons, and other substituents. It was decided 
to determine first the structure of the simplest of the three compounds, compound 
(74). 
Compound (74) had a molecular weight of 326 as deduced from its positive 
and negative FAB mass spectra which exhibited ions at m/z 327 and 325 
corresponding to MH+ and (M-H)· respectively. The EIMS showed the highest ion at 
m/z 164 which corresponded to the aglycone. 
The 1 H NMR spectrum of the compound showed a singlet at 8 3. 7 3 
corresponding to a methoxy group. There were three aromatic protons at 86.99 (J 8 
Hz), 6.65 (J 2, 8 Hz), and 6.78 (J 2 Hz) which corresponded to a 1, 2, 4-substituted 
aromatic ring. The glycosidic substituent had the anomeric proton signal at 84.82 (J 
7 Hz) which implied a ~-linked glycoside. 
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There were also two double doublets at 05.03 (J 1.5, 10 Hz) and 5.05 (J 1.5, 
17 Hz) corresponding to terminal olefinic methylene protons, and a multiplet at 85.91 
(J 6.3, 10, 17) for the olefinic methine proton (Figure 4.2A). It was difficult to assign 
from the 1 D 1 H NMR spectrum which proton the olefinic methine proton at 85. 91 
was coupled to, since from the J value of 6.3 Hz, it could be expected to be coupled 
to an allylic methylene proton. The allylic methylene proton should be observed 
around 83.0-3.5, but due to the overlapping signals of the glycosidic protons between 
83.03-3.87, was not easily assigned. From an analysis of a DQF-COSY (double 
quantum filtered homonuclear correlation spectroscopy) spectrum where the cross-
peaks showed the different 1 H-1 H connectivities, it was possible to assign the proton 
signals for the allylic group. 
The cross peaks (H8/H9a and H8/H9b) showed the coupling between the 
olefinic methine proton (05.91) with the olefinic methylene protons at 85.03 and 5.05 
respectively (Figure 4.2B). The COSY spectrum also showed the coupling (H7 /HS) 
of the same olefinic proton (05.91) to another proton at 03.28 which was assigned as 
the allylic methylene protons. It could then be deduced that the compound (74) was a 
~-glycoside of an aromatic compound containing allylic and methoxy substituents. 
The 13C NMR spectrum supported the proposed structure (74). There were 
carbon resonances corresponding to the methoxy signal at 55.6 ppm, the anomeric C-
l' of the glycoside at 100.2 ppm and the glycosidic carbons between 60 and 77 ppm 
of a glucopyranoside. The signals for the olefinic carbon atoms were observed at 
139.0 and 115.6 ppm but the allylic carbon signal which was expected at around 40 
ppm was not easily assigned from the lD 13C spectrum since the sample was run in 
d6-DMSO (solvent peak at 39.5 ppm). 
A 
B 
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H9b H9a 
I I I I I I I I I I I I I I I I I I I I I I I I 
I I I I I I I I I I I I I I I I I I ' 
5.08 5.02 ppm 
11 I I I I I II 11 I 11 
3.32 3.26 ppm 
H7 
H9a 
6.00 5.94 5.88 ppm 
H8 
'X 
j H9a 
H9b 
• 
w. . 
H8/H9a 
H8/H9b r#. 
H7 
H7/H8 I 
6.e 5 . 8 5 . 6 5.4 5.2 5.0 4.8 4.6 4.4 4.2 4.0 3.8 3.6 3.4 
Fl Cppm) 
Figure 4.2. A. The ID 1 H NMR signals of the allylic protons in eugenol glucoside 
(74). B. DQF-COSY spectrum showing the interactions among the allylic protons in 
eugenol glucoside (74). 
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T bl 4 2 13C NMR d t t d (74) (75) (76) d (77) a a e .. a a or compoun s 
' ' 
an 
Carbon No. (74) (75) (76) (77) 
1 144.9 145.0 144.9 135.4 
2 148.9 148.9 148.9 152.6 
3 112.9 113.0 112.9 106.5 
4 133.4 133.6 133.4 132.8 
5 120.3 120.5 120.3 106.5 
6 115.9 115.7 115.5 152.6 
7 39.5 39.5 38.9 41.3 
8 139.0 138.0 137.9 137.5 
9 115.6 115.7 115.5 115.9 
OCH3 55.6 55.7 55.6 56.3 
OCH3 - - - 56.3 
1' 100.2 100.5 100.2 102.7 
2' 73.2 73.2 73.2 74.1 
3' 77.0 76.8 77.0 76.5 
4' 69.7 70.0 69.7 69.9 
5' 76.9 76.8 76.8 77.2 
6' 60.7 63.2 60.6 60.9 
1" - 109.4 -
2" - 75.6 -
3 II 
- 76.0 -
4" 
- 70.0 -
5" 
- 67.8 -
Unassigned 24.6, 28.5, 76.7, 76.8 and 
34.0, 38.8, weak 103.4, 
174.8 104.5, 175.7 
a 8 in ppm from 39.5 in d6-DMSO at 75.5 MHz. 
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The assignment of the allylic carbon was confirmed from the HMQC 
(heteronuclear multiple quantum coherence) experiment which showed the 
correlation between directly bonded 1 H-13C nuclei by inverse detection (i.e., 13C are 
detected through their effects on the more sensitive 1 H nuclei). From the spectrum 
obtained, the correlation between the allylic proton at 03.28 and a carbon signal at 
39.5 ppm was observed in addition to the 1 H-13C correlation expected for the solvent. 
This confirmed the assignment of the allylic carbon at 39.5 ppm. 
Methanolysis of the compound (74) followed by trimethylsilylation and 
subsequent GC-MS of the product mixture showed the presence of the TMSi 
derivative of the aglycone (80), and the tetra-TMSi derivative of methyl 
glucopyranoside (both a- and ~-anomers) (81). 
m/z 236, W 
(80) 
OSiM~ 
Me3Si0 
Me3SiO~ ...... --
OSiMe3 
OCH3 
mlz 435, (M+·-CHTCH20H) 
(81) 
The proposed structure then is a 0-~-D-glucopyranoside of eugenol. The 
site of substitution on the aromatic ring as well as the assignments of the carbon 
resonances was based on the HMQC and HMBC experiments. The key HMBC 
correlations for the aglycone portion are shown in Figure 4.3. 
H 
Figure 4.3. Key HMBC correlations for the assignment 
of the carbon resonances of the aglycone in compound (74) 
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A survey of the literature showed that eugenylglucoside (74) was extracted 
from Melissa officinalis in 1988154, acetylated and then purified by silica gel 
chromatography. The compound was regenerated by deacety lation using N aOMe, 
and the substituents determined by enzymic hydrolysis and subsequent GC-MS of the 
products. There was no mass spectral data reported for the compound but their 
reported 1 H and 13C NMR values were comparable to the spectral data obtained in 
this study. 
The presence of a sugar conjugate of eugenol has also been recorded in cell 
cultures of Ocimum basilicum, but the compound was neither isolated nor 
identified.155 In another paper, isolation of a eugenol glycoside ( citrucin C) from 
Citrus peelings has been reported and found to lower blood pressure, but it was stated 
that the NMR characteristics did not correspond with those obtained for the 
compound from Melissa officinalis.154 The same glycoside (citrucin C) was also 
isolated from the aerial parts of Pluchea indica.156 A related compound with an 
additional glucoside at C-6' has been isolated from the water-soluble portion of 
Asiasari radix, but its biological activity was not mentioned.157 
Compound (75) had a basic structure similar to eugenol glucoside (74) as 
deduced from its 1 H and 13C NMR spectra (Table 4.2). The only difference was the 
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presence of an additional glycoside substituent. EIMS of the compound again 
showed the A+ ion at m/z 164 corresponding to the eugenol portion. The positive and 
negative F AB mass spectra of the compound showed significant ions at m/z 459 and 
457 which could be assigned to MH+ and (M-H)- respectively, corresponding to 
compound (74) with an additional 132 mass units (i.e., a pentose sugar). 
The 13 C NMR spectrum of the compound showed the signals for the 
methoxy (55.7 ppm), allylic (39.5, 139.0, 115.6 ppm) and glycosidic substituents of 
the aromatic ring. There was, however, an additional anomeric carbon signal at 109.4 
ppm and a set of glycosidic carbon resonances between 67 and 76 ppm corresponding 
to a xylopyranose substituent. 158 A comparison of the carbon resonances of the 
glucoside in (75) with that of the unsubstituted glucoside in (74) implied the presence 
of the xylose substituent at C-6'. 
GC-MS of the silylated methanolysis products of compound (75) again 
showed the presence of the trimethylsilyl derivatives of eugenol (80) and methyl 
glucopyranoside (81). There was also an additional product with an (M+ · -CH3-
CH20H) at m/z · 333 which could be assigned to the trimethylsilyl derivative of 
xylopyranoside (82). Compound (75) then is a ~-xylopyranosyl-(1->6)-~-D-
glucopyranosyl derivative of eugenol. 
Me3SiO 
Me3 SiO----... ...... --
mlz 333, (M+·-CHTCH20H) 
(82) 
Compound (76) was also a derivative of eugenol glucoside (74). The 
compound had a molecular weight of 418 as deduced from the significant ions at m/z 
419 and 417 in the positive and negative FAB-mass spectra corresponding to 
MH+and (M-H)- respectively. The same molecular mass was deduced from the 
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matrix-assisted laser desorption ionization mass spectrum (MALDI-MS) of the 
compound which showed an intense (M+Na)+ ion at m/z 441. 
The 1 H NMR spectrum of the compound was very similar to those of 
compounds (74) and (75). The same aromatic protons of a 1, 2, 4-substituted 
aromatic ring were present. The methoxy proton at 83.72 and the allylic protons at 
83.28, 5.02, 5.05 and 5.92 implied the presence of the eugenol aglycone. 
As shown in Table 4.2, all the carbon resonances in the 13C NMR spectrum 
of (76), corresponding to the eugenol portion as well as the glucoside portion were 
comparable to those in compound (74). The only differences were in the additional 
resonances at 24.6, 28.5, 34.0, 38.8 ppm and a weak signal at 174.8 ppm. 
Methanolysis and silylation of the compound (76) and subsequent GC-MS of 
the product mixture again showed the presence of the trimethylsilylated derivative of 
eugenol (80), and the trimethylsilyl derivative of methyl glucopyranoside (81). This 
information implied that the compound was also a glucoside of eugenol. However, 
the additional carbon signals could not be assigned. The number of carbon atoms and 
the hydrogen atoms (from HMQC experiment), do not add up to the 92 additional 
. mass units, which was the difference between the molecular weight of the parent 
compound (74) and compound (76). The possibility that the additional mass units 
was a glycerol (MW 92) adduct from the matrix had been ruled out since the same 
molecular mass was observed from the MALDI-MS. It can only be deduced at this 
stage that whatever the substituent is , it could only be attached to the glycosidic part 
of the molecule since the eugenol portion remains intact based on the NMR data. 
More experiments are still needed to be carried out, which was not possible in this 
study with the limited time available. 
Compound (77), which was isolated from the same fraction as compounds 
(7 4 ) and (7 5 ), did not show the characteristic proton and carbon resonances of 
eugenol glucoside (74). Negative FAB-MS of the compound showed significant ions 
at ,n/z 421 and 355. GC-MS of the silylated methanolysis products showed the 
122 
presence of two major compounds with M+ at m/z 266 and (M+·-CH3-CH20H) at m/z 
435. 
The 1 H NMR spectrum showed an aromatic proton at 86.47 and a strong 
methoxy signal at 83.70. There were also the allylic protons at 83.28, 4.09, 4.93 and 
5.04 but the anomeric proton(s) was (were) not easily identified. The 13C NMR 
spectrum of the compound (Table 4.2) also showed the strong methoxy signal at 56.3 
ppm and the signals for the allylic substituent at 41.3, 115.9 and 137.5 ppm. There 
were also strong signals at 106.5 and 152.5 ppm and (at least) one anomeric carbon at 
102. 7 ppm. From these, it could be deduced that compound (77) was also a 
phenylpropanoid glycoside. However, unlike eugenol glycoside (74), it had two 
methoxy substituents in the same chemical environment which gave rise to the strong 
signals of the methoxy carbon and the aromatic carbon atoms where they were 
attached. 
OH 
OR 
(77) 
The correlations obtained from the HMQC and HMBC experiments further 
confirmed the proposed partial structure. The presence of an additional methoxy 
group at C-6 could explain the observed aromatic carbon resonances. The key 
HMBC correlations (Figure 4.4) helped establish the assignments of the carbon 
resonances in the aglycone. It is also worth noting at this point, that the presence of 
an additional methoxy group in the aromatic ring could explain the observed silylated 
methanolysis product with M+ at m/z 266 which was assigned structure (84). 
glc-0 
Figure 4.4. Key HMBC correlations for 
the aglycone of compound (77) 
m/z 266, W 
(84) 
. . 
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The number of monosaccharide units in the glycosidic portion cannot be 
confirmed at this stage. There was at least one strong signal for an anomeric carbon 
at 102.7 ppm. There were also at least other five carbon signals between 60-70 ppm 
which could be assigned to the carbon resonances of a P-D-glucopyranoside. The 
presence of glucose was also supported by the observed mass spectrum of the 
silylated methanolysis product (81). 
However, there were weak carbon signals around 100 ppm which could 
possibly be assigned to anomeric carbons. The DQF-COSY spectrum also showed 
weak correlations for overlapping signals between 83-4. Whether these apparent 
sugar resonances were substituents of compound (77) or just impurities in the 
solution could not be ascertained. 
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The observed ion in the (-)FAB-MS at mlz 355 could account for the 
aglycone (194 mu) and one glucose unit (162 mu). However, the ion(s) above mlz 
355 implied that there could be other substituent(s) on the glycosidic portion. Further 
work is required to confirm the structure of the glycosidic portion of the compound 
(77). 
The compound 4-allyl-2,6-dimethoxyphenyl glucoside was first isolated 
from Macrolinidium trilobum.159 Structure elucidation was carried out by enzymatic 
hydrolysis to yield glucose and the aglycone which was compared to synthetic 4-
allyl-2,6-dimethoxyphenol. The same compound had also been reported156 from the 
aerial parts of Pluchea indica, as part of a study on the glycosides from Compositae. 
Compound (78) had a molecular mass of 388 as deduced from its positive 
and negative FAB-MS which exhibited ions at m/z 389 and 387 corresponding to 
MH+ and (M-H)- respectively. There were also significant ions at mlz 227 and 225 
corresponding to a loss of 162 mu. 
11 12 OH H3C CH3 
OH 
2 
8 
0 CH3 OH 13 
OH 
(78) 
The 1 H NMR spectrum of the compound exhibited the presence of four 
methyl groups at 81.06, 1.10, 1.34 and 1.86, three methine protons at 83.89, 4.20 and 
4.24, methylene protons at 81.62, and trans olefinic protons at 85.56 and 6.21 (J 16 
Hz). There were also protons characteristic of a hexose substituent linked by a ~-
glycosidic bond (anomeric proton at 84.31 J 7 Hz). 
The 13c NMR spectrum (Table 4.3) confirmed the presence of four methyl 
groups which showed resonances at 19.8, 21.2, 27.5 amd 30.1 ppm, a methylene 
carbon at 40.2 ppm and a saturated quaternary carbon at 37 .2 ppm. There were also-
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two sets of olefinic carbon atoms at 128.2, 130, 136.9 and 142.4 ppm, three oxy-
substituted carbon atoms at 67 .6, 71.9 and 80.0 ppm, as well as the resonances 
corresponding to a glucose substituent. These led to the deduction that the compound 
was a terpenoid glucoside. The different correlations obtained from DQF-COSY, 
HMQC and HMBC experiments further confirmed the proposed structure (78). 
T bl 4 3 13C NMR d t f a e .. a a or: compoun d (78) 
Carbon No. D2oa C5D5N156 Carbon No. D2oa 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
37.2 36.9 11 30.1 
40.4 39.7 12 27.5 
67.6 74.7b 13 19.8 
71.9 68.8b 1' 101.7 
· 128.2 125.0 2' 74.4 
142.4 141.3 3' 76.7 
130.0 127.9 4' 70.2 
136.9 141.3 5' 76.9 
80.0 68.2b 6' 61.4 
21.2 24.7 
a 8 from TMS, CD30D as internal reference, 75 .5 MHz 
b Assignment may be interchanged.156 
C5D5N156 
27.4 
30.0 
20.2 
101.6 
75 .6 
79.0 
71.7 
78.7 
62.8 
A review of the literature showed that the compound (78) had been isolated 
from Pluchea indica and named plucheoside B, together with eugenol glycoside 
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(citrusin C) (74) and 4-allyl-2,6-dimethoxyphenyl glucoside during a study on the 
glycosides in some plants of the Compositae.156 The reported 13C NMR values 
(Table 4.3) were comparable to the values obtained in this study except for minor 
differences considering that the samples were run in different solvents. The present 
assignments of the carbon resonances were deduced from the HMQC spectrum and 
from the long-range correlations obtained from the HMBC experiment (Figure 4.5). 
glcO 
OH 
Figure 4.5. Key HMBC correlations for the 
aglycone of compound (78) 
In summary, the Philippine medicinal plant W. prostata did not contain the 
toxic terpenoid glycosides similar to wedeloside or atractyloside. The extracts 
yielded diterpenoic acids and eugenol glycosides, which have potential 
pharmacological activities, and the terpene glycoside plucheoside B. The presence of 
these compounds in the plant might be responsible for its folk medicinal applications, 
but further studies are needed to confirm this. 
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C. Experimental 
General experimental procedures are given in Chapter 2. 
1. General Isolation Procedure 
W. prostata (in its vegetative stage) was collected from the College of 
Forestry, University of the Philippines at Los Bafios, Laguna. The plants were air-
dried for one week, and the leaves oven-dried at 30°C overnight then ground on a 
Wiley mill (30-40 mesh). 
The milled, dried leaves (275g) were extracted twice with 1: 1 MeOH/H20 
( 1.5L) using a mechanical shaker. The suspension was filtered and the filtrate 
concentrated under vacuum removing most of the methanol. The aqueous residue 
was extracted with hexane, dichloromethane, ethyl acetate, then with n-butanol. 
Purification of the hexane extract was carried out by repeated column 
chromatography using increasing concentrations of ethyl acetate in light petroleum 
resulting in partially purified fractions. The first fraction containing the major 
components (as checked from TLC), were further purified by CTLC and yielded a 
mixture of the kaurenoic acids (72) and (73). Further purification was attempted by 
HPLC using a Nitrile column connected to an RI detector, with different 
concentrations of ethyl acetate in hexane as solvent, but still resulted in the mixture of 
the two kaurenoic acids. Using 10% EtOAc/hexane as solvent at 2 ml/min, the 
kaurenoic acids (72) and (73) eluted after 12.57 min. A more polar fraction of the 
hexane extract yielded another major component, the phytosterol (71) after repeated 
CTLC, and final purification by HPLC. 
The ethyl acetate and dichloromethane fraction of the MeOH/H20 extract 
were discarded while purification was carried out on the n-BuOH extract. The n-
BuOH fraction was concentrated under vacuum, and the residue was added with 
EtOAc/MeOH (2:8) after observing that the residue had MeOH-soluble and non 
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MeOH-soluble components. The resulting mixture was filtered and the filtrate 
concentrated in vacuo then passed through Sephadex LH-20 using 10% H20/MeOH 
as eluent. The partially purified fractions were passed through a short reversed-phase 
C-18 column and eluted first with 1: 1 MeOH/H20 and then with MeOH. Repeated 
RP-HPLC of the second fraction yielded compound (76). 
The less MeOH soluble components in the residue were dissolved in H20 
and passed through Sephadex LH-20 using 1: 1 MeOHIH20 as eluent. The partially 
purified fractions obtained were further purified using repeated RP-HPLC and 
yielded compounds (74), (75), (77) and (78). The HPLC conditions used in the final 
purification of the different polar components isolated are included in the following 
description/data of each compound. 
2. Physical Data of Isolated Compounds 
(-)-ent-Kaur-16-en-19-oic acid (72). 13C NMR (CDCl3, 75.5 MHz) 15.6 
(C-20), 18.4 (C.-11), 19.1 (C-2), 21.8 (C.-6), 29.0 (C-18), 33.1 (C-12), 37.8 (C-3), 
39.7 (C-14), 39.7 (C-10), 40.7 (C-1), 41.3 (C-7), 43.7 (C-4), 43.8 (C-13), 44.2 (C-8), 
49.0 (C-15), 55.1 (C-9), 57.1 (C-5), 103.0 (C-17), 155.8 (C-16), 184.8 (C-19). 
Grandiflorenic acid, (4a)-kaura-9(11),16-dien-19-oic acid (73). 13C NMR 
(CDCl3, 75.5 MHz) 18.4 (C-6), 20.1 (C-2), 23.6 (C-20), 28.2 (C-18), 29.7 (C-7), 
37.9 (C-12), 38.2 (C-3), 38.8 (C-10), 40.7 (C-1), 41.2 (C-13), 42.3 (C-8), 44.7 (C-4), 
44.9 (C-14), 46.6 (C-5), 50.3 (C-15), 105.5 (C-17), 114.9 (C-11), 155.9 (C-9), 158.5 
(C-16), 184.7 (C-19). EIMS (mixture) of (72) and (73) m/z 302 (M+, 9o/o), 300 (M+, 
5), 285 (14), 259 (10), 131 (24), 105 (51), 91 (76), 55 (100). 
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Poriferasterol (71), 3/3, 22E, 24R. M.p. 154-156°C (lit146 154°C). [a]o-47 
( 1.0mg/ml in CHCl3). EIMS m/z 412 (M+, 5% ), 351 (2), 300 (3), 271 (3), 255 (7), 
213 (3), 133 (12). 13C NMR (CDCb, 75.5 MHz) 12.1 (C-29), 12.3 (C-18) , 19.0 (C-
26), 19.4 (C-19), 21.1 (C-11), 21.1 (C-21), 21.2 (C-27), 24.4 (C-15), 25.4 (C-28), 
28.9 (C-16), 31.6 (C-2), 31.9 (C-7), 31.9 (C-8), 31.9 (C-25), 36.5 (C-10), 37.2 (C-1), 
39.7 (C-12), 40.5 (C-20), 42.2 (C-13), 42.3 (C-4), 50.1 (C-9), 51.2 (C-24) , 55.9 (C-
17), 56.9 (C-14), 71.8 (C-3), 121.7 (C-6), 129.2 (C-23), 138.3 (C-22), 140.7 (C-5). 
Eugenol glucoside (74), 15413mg. HPLC conditions: 40-55% MeOWH20 at 
3.0 ml/min, over 30 min, curve (-7), 220 nm, Rt 22.0 min. EIMS mlz 164, A+ . 
Negative FAB-MS m/z 325 (M-H)-, (+)FAB-MS m/z 327 MH+. lH NMR (b, d6-
DMSO, 300 MHz) 3.28 (d, 2H J 6.3, H-7) , 3.03-3.87 (m, 6H, H-2' to H-6') , 3.73 (s, 
3H, 2-0CH3), 4.82 (d, lH J 7, H-1'), 5.03 (dd, lH J 1.5, 10, H-9a) , 5.05 (dd, lH J 
1.5, 17, H-9b), 5.91 (ddt, lH J 6.3 , 10, 17, H-8), 6.65 (dd, lH J 2,8 , H-5), 6.78 (d, 
lH, J 2, H-3) , 6.99 (d, lH J 8, H-6). 13C NMR, see Table 4.2. GC-MS of silylated 
methanolysis products showed two major compounds. Compound (80), Rt 7 .96 min, 
MS mlz 236 (M+) , 206, 179, 149, 131. Compound (81) (a and ~-anomers) , Rt 13.16 
and 13.40 min, MS m/z 435 (M+·-CH3-CH20H), 377 (M+·-CH3-TMSiOH) 305 , 290, 
217, 204, 133, 73. 
Eugenol /3-xylopyranosyl-( 1->6)-/3-D-glucopyranoside (75) , 10.8mg. 
HPLC conditions: 40-55o/o MeOWH20 at 3.0 ml/min, over 30 min, curve (-7), 220 
nm, R120.1 min. EIMS m/z 164 (A+, 100%), 133 (24), 91 (22). Negative FAB-MS 
m/z 457 (M-H)-, (+)FAB-MS m/z 459 MH+. lH NMR (b, d6-DMSO, 300 MHz) 
3.29 (d, 2H J 6.6, H-7), 3.05-3.71 (m, 1 lH, H-2' to H-6', H'-2" to H-5"), 3.72 (s, 3H, 
2-0CH3), 4.78 (d, lH J 8, H-1 ') ,4.79 (d, lH J 7, H-1 "), 5.03 (dd, lH J 1.5, 10, H-9a), 
5.04 (dd, lH J 1.5, 17, H-9b), 5.93 (ddt, lH J 6.6, 10, 17, H-8), 6.65 (dd, lH J 2,8, 
H-5), 6.78 (d, lH, J 2, H-3), 6.99 (d, lH J 8, H-6). 13C NMR, see Table 4.2. GC-
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MS of silylated methanolysis products showed three major compounds. Compound 
(80), Rt 7.98 min, MS m/z 236 (M+), 206, 179, 149, 131. Compound (81) (a and~-
anomers), Rt 13.14 and 13.39 min, MS mlz 435 (M+·-CH3-CH20H), 377 (M+·-CH3-
TMSiOH), 305, 290, 217, 204, 133, 73. Compound (83), Rt 9.03 min, MS m/z 333 
(M+-CH3-CH20H), 305, 259, 217, 191, 147, 103, 73. 
Eugenol glycoside analog-qe (76), 5.9mg. HPLC conditions: 15-40% 
MeOH/H20 at 3.2 ml/min, over 30 min, curve (-2), 220 nm, Rt 33.2 min. Negative 
FAB-MS m/z 417 (M-H)-, (+)FAB-MS m/z 419 MH+, MALDI-MS m/z 441 
(M+Na)+. lH NMR (8, d6-DMSO, 300 MHz) 1.28 (s, 2H), 1.45 (m, 2H), 2.15 (t, 
lH), 3.28 (d, 2H J 6.3, H-7), 3.03-3.69 (m, 6H, H-2' to H-6'), 3.72 (s, 3H, 2-0CH3), 
4.82 (d, lH 17, H-1'), 5.02 (dd, lH J 1.5, 10, H-9a), 5.05 (dd, lH J 1.5, 17, H-9b), 
5.92 (ddt, lH J 6.3, 10, 17, H-8), 6.65 (dd, lH J 2,8, H-5), 6.78 (d, lH, J 2, H-3), 
6.98 (d, lH J 8, H-6). 13C NMR, see Table 4.2. GC-MS of silylated methanolysis 
products showed two major components. Compound (80), Rt 7.96 min, MS m/z 236 
(M+), 206, 179, 149, 131. Compound (81) (a and ~-anomers), Rt 13.16 and 13.4 
min, MS m/z 435 (M+-CH3-CH20H), 377 (M+·-CH3-TMSiOH), 305, 290, 217, 204, 
133, 73. 
4-Allyl-2,6-dimethoxyphenyl glucoside derivative (77), (12mg) HPLC 
conditions: 40-55o/o MeOH/H20 at 3.0 ml/min, over 30 min, curve (-7), 220 nm, Rt 
24.3 min. Negative FAB-MS m/z 355,421. lH NMR (8, d6-DMSO, 300 MHz) 3.28 
(d, 2H J 6.3, H-7), 3.03-4.50 (m, glycosidic protons), 3.70 (s, 6H, 2-0CH3, 6-0CH3), 
4.90 (dd, lH J 1.5, 10, H-9a), 5.04 (dd, lH J 1.5, 17, H-9b), 5.93 (ddt, lH J 6.3, 10, 
17, H-8), 6.48 (s, 2H, H-3, H-5). 13C NMR, see Table 4.2. GC-MS of silylated 
methanolysis products showed two major components. Compound (84), Rt 9.80 min, 
MS m/z 266 (M+), 236, 205, 179, 151, 118, 89, 73. Compound (81) (a and~-
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anomers), Rt 13.16 and 13.4 min, MS m/z 435 (M+·-CH3-CH20H), 377 (M+·-CH3-
TMSiOH), 305,290,217,204, 133, 73. 
Plucheoside B (78). HPLC conditions: 35-55o/o MeOH/H20 at 3.0 ml/min, 
over 20 min, curve (-9), 220 nm, Rt 15.9 min. Negative FAB-MS mlz 387 (M-H)-, 
225. (+)FAB-MS m/z 389 MH+, 227. lH NMR (b, D20, 300 MHz) 1.06 (s, 3H, H-
11), 1.10 (s, 3H, H-12), 1.34 (d, 3H, H-10), 1.64 (dt, 2H J 13, H-2), 1.86 (s, 3H, H-
13), 3.52-4.09 (m, 6H, H-2'-H-6'), 3.89 (m, lH, H-3), 4.20 (m, lH, H-4), 4.24 (m, 
lH, H-9), 4.31 (d, lH 17, H-1'), 5.56 (d, lH J 16, H-8), 6.21 (d, lH J 16, H-7). 13C 
NMR, see Table 4.3. 
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